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Abstract
The rapid development and applications of high throughput measurement techniques bring the
biological sciences into a 'big data' era. The vast available data for enzyme and metabolite
concentrations, fluxes, and kinetics under normal or perturbed conditions in biological networks
provide unprecedented opportunities to understand the cell functions. On the other hand, it brings
new challenges of handling, integrating, and interpreting the large amount of data to acquire
novel biological knowledge. In this thesis, we address this problem with a new ordinary
differential equation (ODE) model based on the mass-action rate law (MRL) of the biochemical
reactions. It describes the detailed biochemical mechanisms of the enzyme reactions, and
therefore reflects closely of how the enzymes work in the systems. Because the MRL models are
constructed with elementary enzyme reaction steps, it is also much more flexible than the
aggregated rate law (ARL) model to incorporate new enzyme interactions and regulations. Two
versions of the MRL model ensembles for the central carbon metabolic network, which generates
most of the precursors for the secondary metabolite, were constructed. The E. coli version
contains the basic reactions in this network and was applied to optimize the aromatic amino acid
production which requires fine-tuned flux partition between glycolysis pathway and the pentose
phosphate pathway. The S. cerevisiae version is more sophisticated with the incorporated
dynamics of the NAD/NADH and NADP/NADPH, as well as the automatic switch from aerobic
to anaerobic condition. It was applied to maximize the ethanol production yield, for which the
NAD/NADH ratio is a crucial regulating factor. In order to develop methodologies to understand
the intrinsic network properties and optimize the network behavior, we further explored
approaches for the identification of pathway bottlenecks. Four computational assays were studied,
including metabolite accumulation, conditional Vmax, increased glucose input, and decreased Eo,
which were applied to the ethanol model ensemble to discover their effectiveness in bottleneck
identification in this network. The TDH reaction was detected as a major bottleneck restricting
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carbon flow towards the ethanol pathway and affecting NADH availability. To manipulate the
network for desired production rates of target metabolites, we developed an optimization
technique for mass-action rate law ODE models that allows parallel or sequential combinations
of enzyme knock-out and over-/under-expression strategies to be conducted on the model. Many
strategies were suggested to improve the aromatic amino acid production and help identify the
two-direction flux feature of the pentose phosphate pathway. Strategies were also found to
enhance the ethanol production yield above 95% of the theoretical yield. Although the two
applications studied here are both in the field of metabolic engineering, it is anticipated that the
mass-action rate law models for the central carbon metabolism can be extended to study the
cancer metabolism. Preliminary studies show promising results for designing cancer clinical trial
simulations with a combined model incorporating high level cancer progression and detailed
cancer biochemical metabolism.
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Chapter 1
Introduction
High-throughput technologies in biological and medical studies have improved significantly
in quality while reducing their cost in the past decade, which has led to the generation of large
data sets describing biological network topology, enzyme kinetic behavior, biochemical reaction
dynamics, and species concentrations. Free access to these data sets makes it possible to create
quantitative models for large-scale biological networks that describe their behavior at the
mechanistic level. High-quality mechanistic models are expected to be capable of providing
critical insights into the behavior of biological networks and thus lead to the development of new
biological knowledge and guide experiments in network re-engineering. With proper control of
uncertainty, computational modeling can save researchers in academia and industry both time
and money by providing valuable predictions, prototyping experiments, and directing design.
Modeling can also help to discover important but sometimes hidden network properties, such as
alternative network states or intrinsic bottlenecks. New techniques are needed to manipulate
these detailed and often complex models in order to develop strategies that optimize network
behavior to suit biomedical or biotechnological goals. More than just the construction of
computational models, the development of strategies for studying, analyzing, and designing with
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these models provides tremendous potential for impact and growth of capabilities, particularly to
advance metabolic engineering and medical applications.
1.1 Computer-aided biological network analysis and optimization
With biology increasingly becoming a data-rich field, an emerging challenge is how to
organize, sort, interrelate, and contextualize all of the high-throughput data sets becoming
available. Most of these data sets are large enough to exceed the human ability to directly read
out deep biological knowledge. Traditional biological techniques are no longer enough to
efficiently interpret these large data sets. This challenge has motivated the field of computational
and systems biology, wherein computational and statistical analyses of high-throughput data are
used to infer biochemical network structure, function, and response to stimulation and
intervention. During the past few decades, most of efforts in computational and systems biology
have been focused on solving three major problems: reconstruction of biological networks,
simulation of network responses, and optimization of network behaviors. Two classes of
biological systems, gene expression regulatory networks and metabolic networks, have received
the most attention and are used as case studies to develop novel computational methodologies.
Many modeling techniques have been developed to infer or 'reverse-engineer' gene networks
(Bansal et al., 2007), which is defined as the process of identifying gene interactions from
experimental data through computational analysis, including clustering (Amato et al., 2006;
Eisen et al., 1998), Bayesian analysis (Friedman et al., 2000; Yu et al., 2004), information
theoretic approaches (Margolin et al., 2006; Steuer et al., 2002), and ordinary differential
equation modeling (Bansal et al., 2006; Gardner et al., 2003; di Bernardo et al., 2005). These
methodologies generally utilize steady-state gene expression data or short time-series data to
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infer gene interactions and have different performance depending on the quality of the data and
the network properties (Bansal et al., 2007). With the vast availability of genome sequence data,
the genome-scale metabolic reconstructions have also exploded during the past decade
(Oberhardt et al., 2009). Since the publication of the first genome-scale metabolic reconstruction
of Haemophilus influenza (Edwards & Palsson, 1999), the field of genome-scale metabolic
network analysis has expanded rapidly, and more than 50 genome-scale metabolic
reconstructions have been published.
With the expanded use of computational techniques, many models have been constructed for
biological networks, and network topologies as well as molecular mechanisms through which
regulation is achieved have been identified and reported in several major databases (e.g., KEGG
(Kanehisa & Goto, 2000), BRENDA (Scheer et al., 2010)). However, our understanding of the
functioning of the regulatory systems is still insufficient for many applications. Nevertheless,
techniques to simulate models and develop novel knowledge are important research frontiers.
Simulation techniques have been developed for different formalisms, including directed graphs,
Bayesian networks, Boolean networks and their generalizations, ordinary and partial differential
equations, qualitative differential equations, stochastic master equations, and rule-based
formalisms (de Jong, 2002). The biological results for gene regulation networks obtained through
these applications have been the subject of several reviews (Endy & Brent, 2001; Hasty et al.,
2001; McAdams & Arkin, 1998; Smolen et al., 2000).
The desire to engineer cellular features to produce desired molecules and other cellular
functions has led to the rapid development of metabolic engineering and synthetic biology, both
of which aim to manipulate microorganisms or other cells in order to optimize desired cell
behavior. Metabolic engineering studies the directed improvement of cellular properties through
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modification of specific biochemical reactions or introduction of new ones with the use of
recombinant DNA technology. There are numerous applications of metabolic engineering
published in the scientific and patent literature, a major effort of which has been on the improved
fermentation production of chemicals of commercial and industrial importance, such as amino
acids, polymers, lipids, and biofuels (Alper & Stephanopoulos, 2009; Atsumi & Liao, 2008;
Bailey, 1991; Barkovich & Liao, 2001; Bongaerts et al., 2001; Cameron & Tong, 1993; Cameron
& Chaplen, 1997; Keasling, 1999; Li & Vederas, 2009; Stephanopoulos & Sinskey, 1993; Tyo et
al., 2007). Synthetic biology aims to modify cellular behavior to perform new tasks and construct
complex networks in single-cell and multicellular systems. Recent achievements include the
development of sophisticated non-native behaviors such as bi-stability, oscillations, proteins
customized for biosensing, optimized drug synthesis, and programmed spatial pattern formation
(Andrianantoandro et al., 2006; Benner & Sismour, 2005; Khalil & Collins, 2010; McDaniel &
Weiss, 2005). For both metabolic engineering and synthetic biology, computational modeling
and optimization play crucial roles. Research can be done utilizing the strengths of both (Lee et
al., 2008).
1.2 Mechanistic modeling of metabolic networks
Metabolic networks, especially the central carbon metabolic network, are popular targets for
developing modeling techniques, because they are among the best studied networks with well
studied network topology, regulation, and measurement data. Escherichia coli has gained the
most attention as a model organism given the mature techniques for DNA manipulation of its
genome (Oberhardt et al., 2009). Saccharomyces cerevisiae is also a frequently used model
organism due to its popularity in producing industrial alcohol. Many of the desired metabolic
20
products are end or intermediate compounds of the central carbon metabolic network, which
usually includes the glycolysis pathway and the pentose phosphate pathway. Twelve well-known
precursor metabolites serve as branch points from the central carbon metabolic network to
generate biomass, and nine of them sit in glycolysis and the pentose phosphate pathway
(Neidhardt et al., 1990). Glucose is the main carbon input of the central carbon metabolic
network. It is oxidized via either glycolysis to generate ATP and metabolic intermediates, or the
pentose phosphate pathway to yield ribose 5-phosphate for nucleic acid synthesis and NADPH
for reductive biosynthetic processes. For most eukaryotic cells and many bacteria living under
aerobic conditions, pyruvate produced by glycolysis is further oxidized to H20 and CO 2 via the
citric acid cycle (TCA cycle), in the process generating significant energy in the form of ATP
(Nelson & Cox, 2008). In order to maximize the production yield of the desired metabolites by
designing and predicting productive modifications to this complex network, considerable effort
has been put into developing a quantitative understanding and mathematical description of
central carbon metabolism. Several mathematical models of various types have been developed
and applied over the past few decades, including flux balance analysis (FBA) and ordinary
differential equation (ODE) models (Burgard et al., 2003; Chassagnole et al., 2002; Edwards &
Palsson, 2000; Pramanik & Keasling, 1998; Schmid et al., 2004; Usuda et al., 2010; Vital-Lopez
et al., 2006). The FBA model is one of the most widely used model types in the field of
metabolic engineering. It requires relatively modest information regarding biological
mechanism, which usually includes a list of chemical reactions with their stoichiometry, flux
constraints, and specification of feeds and metabolic demands (Kauffman et al., 2003;
Stephanopoulos et al., 1998; Varma & Palsson, 1994). Most of the information can be readily
acquired from existing literature and databases (e.g., KEGG (Kanehisa & Goto, 2000) and
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BRENDA (Scheer et al., 2010)). A set of linear equations is constructed from the stoichiometry
of the reactions so that the fluxes going in and coming out from a node (metabolite) of the
network are the same. The fluxes of each branch of the network at steady state can then be
learned by solving this set of equations. Therefore, FBA models have advantages when modeling
large-scale (e.g., whole genome) networks. However, the steady-state condition is assumed for
FBA models, which usually leads to an underdetermined set of equations with a continuous
space of acceptable solutions. In practice, maximizing biomass production on the assumption
that evolution would favor such solutions or minimizing metabolic adjustment (MOMA), in
which it is assumed that metabolic fluxes in a knock-out strain undergo minimal redistribution
with respect to the flux configuration of the wild type (Segre et al., 2002), is used in order to
obtain a unique solution. The risk is if the assumptions are not valid, the optimal FBA solution
may not correspond to the observed flux distribution in the cell (see review by Edwards et al.,
2002). Yet, this condition becomes problematic for mutant strains, in which evolution may not
have achieved optimality. Therefore, the predictive ability of FBA can be limited, especially for
mutant strains with gene knock-outs.
In contrast to the steady-state nature of FBA models, ODE models, including the aggregated
rate law (ARL) and the mass-action rate law (MRL) forms, incorporate network dynamics and
are considered to represent the actual enzyme mechanisms of the network (Chassagnole et al.,
2002; Lee et al., 2006; Liao et al., 1996; Tzafriri, 2003). ARL modeling simplifies the
description of a single enzymatic step by aggregating the elementary steps associated with a
specific mechanism into a single reaction, where the rate becomes a sometimes complex and
very non-linear function of the species concentrations involved (Lee et al., 2006; Liao et al.,
1996; Tzafriri, 2003). The rate formulae are usually derived from mass-action laws with certain
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assumptions (e.g., quasi-steady state) or acquired as empirical equations from the literature.
MRL modeling does not simplify the elementary enzymatic reaction steps and includes all
intermediate metabolites as tractable variables, which makes it possible to detect which
intermediate step of the enzymatic reaction causes problem when a certain enzyme becomes
bottleneck of the network. ODE models generally have more parameters than the corresponding
FBA models and require more experimental data to fully determine these parameters. At the
same time, the higher dimensional parameter space makes ODE models more flexible to
incorporate complicated network topologies and regulations. If unconstrained, the space of
steady states reachable by both FBA and ODE models is the same, but ODE models can readily
map the parameter constraints into the kinetically feasible regions of the solution space, whereas
it is not easily transferable to FBA models (Machado et al., 2012).
In this thesis, I present two versions of mass-action rate law model ensembles for the central
carbon metabolic network, one for E. coli and one for S. cerevisiae. The E. coli version contains
the basic reactions in this network and is suitable for analyzing basic network behavior and
optimizing most amino acid productions. The S. cerevisiae version incorporates the dynamics of
the NAD/NADH and NADP/NADPH, as well as the switch from aerobic to anaerobic conditions.
It is thus a more comprehensive tool and can be used for analyzing effects from a wide variety of
experimental conditions, such as different glucose and oxygen conditions. The implemented
oxygen consumption mechanism by oxidative phosphorylation enables the model to convert to
anaerobic condition when oxygen is depleted, which makes it possible to analyze the steady-state
changes for all metabolites in the network after this crucial condition switch. It can also provide
deep insight into the regulatory function of the NAD to NADH ratio on the dynamics of this
network, which is demonstrated as an important regulating factor for the network state. The E.
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coli model was applied to optimize the aromatic amino acid production (Chapter 2) and the S.
cerevisiae model was applied to maximize the ethanol production yield (Chapter 3). They can be
easily extended to study production of other chemicals branching from the central carbon
metabolic network (e.g., high carbon alcohol).
1.3 Techniques for rate-limiting reaction detection and release
Increasing the productivity of target chemicals is the main goal of metabolic engineering.
Although much effort has been made to determine efficient strategies that improve the
production rate of target chemicals, there is less research on how to systematically discover the
bottlenecks in the system--that is, to identify targets for rational genetic engineering. In order to
increase the productivity and yield of metabolite production, researchers have focused almost
exclusively on enzyme amplification or other modifications of the product pathway
(Stephanopoulos & Vallino, 1991). In those studies, an enzymatic reaction is often labeled a
bottleneck if overexpressing that enzyme improves the production of target chemicals (Dai et al.,
2002; LUtke-Eversloh & Stephanopoulos, 2008). However, increased production of many
metabolites requires significant redirection of flux distributions in primary metabolism, such as
glycolysis, the pentose phosphate pathway, and the citric acid (TCA) cycle. It can be especially
challenging to identify bottlenecks in primary metabolism, because of the complexity of network
topology and regulation. Approaches such as metabolic control analysis (Heinrich & Rapoport,
1974; Kacser & Bums, 1973) have received considerable attention. However, their value in
guiding metabolic engineering efforts remains uncertain, given the significant drawback that this
method of only valid in the local neighborhood of the operating point evaluated (Stephanopoulos
& Vallino, 1991). Dynamic sensitivity analysis is another effort to detect bottlenecks in primary
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metabolism, in which relative changes of target metabolite concentration caused by an
infinitesimal percentage change in any enzyme activity are calculated and used to predict
bottlenecks (Shiraishi & Suzuki, 2009). However, this method provides limited insight into the
intrinsic properties of the network that cause those reactions to be bottlenecks. The network
rigidity and principal nodes theory has been developed by Stephanopoulos and Vallino (1991),
which can identify nodes in the network that have inherent resistance to flux partitioning
alterations. This theory is useful to identify branching nodes and enzyme reactions that are
crucial and potentially harder to modify in order to increase the yield of target chemicals.
In this thesis, I present a framework to systematically identify bottlenecks in a biological
network and to study detect their relevance for target chemical production. Four computational
tests, including metabolite accumulation, conditional Vmax, glucose input, and decreased Eo, are
developed, which can be easily and efficiently calculated based on mass-action kinetical models
or ensembles of models. In particular, the conditional Vmax test is able to provide critical insight
into the intrinsic cause of network bottlenecks, which is valuable to guide design strategy
development for production improvements. A detailed description of the bottleneck detection
framework is presented in Chapter 3.
Due to the complex interactions of the central carbon metabolic network, it is usually not
obvious how to manipulate the enzymes in the network for the optimized production of the target
chemicals, even if we may already know where the bottlenecks are in the network. In Chapter 2,
I reported an optimization framework for mass-action kinetic models and their ensembles that
can efficiently identify strategies leading to enhanced aromatic amino acid production. This
optimization method allows enzyme knock-outs, in which an enzyme activity is completely
removed from an organism through genetic disruption, as well as enzyme over- and under-
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expression spanning a range from ten times to one-tenth the unperturbed concentration. All
combinations of single, double, and triple enzyme knock-outs as well as all combinations of one-
and two-enzyme expression changes were constructed and studied for aromatic amino acid
overproduction. Efficient strategies with high confidence even in the presence of parameter
uncertainties were identified. In Chapter 3, this optimization method was further developed into
a sequential single-enzyme over- and under-expression optimization framework. Compared to
the exhaustive multiple-enzyme optimization reported in Chapter 2, the single-enzyme
optimization is much more computationally efficient, as the optimization number required on the
same order of magnitude as the enzyme number in the network; whereas that of the multiple-
enzyme optimization could rapidly increase due to the large number of possibilities of enzyme
combinations. Therefore, the single-enzyme sequential optimization method is a useful technique
to identify efficient enzyme strategies for a large-scale network. The bottleneck identification
and release methodologies developed in this thesis are of general value, and are applicable to
other metabolic products beyond those studied here.
1.4 Anticipated impact on cancer therapy and clinical trial
improvement
In recently years, central carbon metabolism has been increasingly linked to cancer
progression and possible therapies. Described decades ago, the Warburg effect of aerobic
glycolysis is a key metabolic hallmark of cancer; however, its significance remains unclear (Hsu
& Sabatini, 2008; Kroemer & Pouyssegur, 2008). Research has been carried out attempting to
decode the causal relation between enhanced glycolysis and cancer development (Hsu & Sabatini,
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2008), but cancer mechanism and central carbon metabolism are both sufficiently complex that
no simple answer has emerged. The NAD/NADH ratio in cells, however, was reported as being
related to tumor development (Koukourakis et al., 2006). With the capability to model the
NAD/NADH dynamics in the network, it may now be possible to use the central carbon
metabolism model I establish in this thesis to understand cancer mechanisms and predict possible
therapeutic approaches. Some preliminary work has been conducted in this direction, which I
briefly describe here.
To link detailed mechanistic models of central carbon metabolism with higher-level cancer
progression, a cancer progression model can be used with a mutation or growth rate that depends
on the mechanistic model's output. A commonly used cancer progression model from Frank et al.
(2004), which describe the transition from wild-type cells to transformed cells using four
mutation steps with different mutation and reproduction rates, was chosen for this preliminary
test. A much simpler mechanistic model that describes selenium metabolism was used to test this
concept. Dietary selenium supplementation was reported to possibly reduce the risk for prostate
cancer; however, too high selenium levels in cells could potentially increase DNA damage
(Gromer & Gross, 2002; K6hrle et al., 2000; Schrauzer, 2000). We therefore built a simplified
mass-action model of selenium metabolism in which the selenium input can be metabolized into
selenide or methylselenol. The selenide directly can damage DNA and methylselenol can oxidize
H20 2 in the system to reduce DNA damage. We further define the mutation rate in the cancer
progression model to be proportional to the amount of the damaged DNA in the mechanistic one.
By simulating this combined model with different selenium input levels, we are able to observe
different corresponding cancer progression rates, which can be explained by the relative fluxes of
the selenide (DNA damaging) and methylselenol (H20 2 neutralizing). The results indicate that
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this type of model is capable of predicting how intracellular metabolism can affect cancer
progression. Cancer clinical trial simulation can also be established based on this combined
model. The kinetic parameters of the reactions in the selenium mechanistic model can be
sampled from a Gaussian distribution to simulate enzyme activity variations in populations. The
selenium level can also be sampled from a distribution to represent the variation in baseline
selenium in different human individuals. Cancer progression can be efficiently simulated for at
least tens of thousands of individuals. Statistical tests can then be conducted on the cancer
progression simulations to predict the outcome of clinical trials. Preliminary results show that the
outcomes of clinical trials are highly dependent on selenium response curves in human
individuals and pre-screening of patients may be needed in order to appropriately identify
patients who would benefit from dietary selenium supplementation and increase the chance of
positive clinical trial outcomes.
The preliminary results we observed suggest this type of combined model and clinical trial
simulation potential to be extended to other mechanistic metabolism models and can be used to
yield insights into clinical trial design. Further work will be required but there is in principle no
barrier to incorporating the entire central carbon metabolic network into cancer progression
models. Valuable insights about the relation between glycolysis metabolism and cancer
development are anticipated from the analysis of these models.
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Chapter 2
A Mass-Action Rate Law Ensemble Model of
E. coli Central Carbon Metabolism Applied
to Amino Acid Production
Abstract
Two types of computational models that dominate the field of metabolic engineering are flux
balance and aggregated rate law models, both of which have strengths and shortcomings. In this
report, we present a model from a third class, a mass-action rate law (MRL) model, for the E.
coli central carbon metabolic network. This mechanistic model does not require assuming
optimal behavior of the metabolic network as for flux balance modeling and also involves fewer
assumptions than aggregated rate law modeling. To estimate the uncertainty of model predictions
due to parameter uncertainty, an ensemble of sub-models was built using latin hypercube
sampling. The ensemble model was used to identify enzyme expression change strategies for
overproducing aromatic amino acids. The predicted strategies revealed implications of
complexity in the pentose phosphate pathway (PPP) and suggested that fine-tuning both the
direction and volume of the PPP flux can play an important role in improving aromatic amino
acid production. The ensemble model presented here for central carbon metabolism provides
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new opportunities for applying metabolic engineering to the production of commercially and
industrially important chemicals.
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2.1 Introduction
Metabolic engineering studies the directed improvement of cellular properties through
modification of specific biochemical reactions or introduction of new ones with the use of
recombinant DNA technology. There are numerous applications of metabolic engineering
published in the scientific and patent literature, a major effort of which has been on the improved
fermentation production of chemicals of commercial and industrial importance, e.g. amino acids,
polymers, lipids, and biofuels (Alper and Stephanopoulos, 2009; Atsumi and Liao, 2008; Bailey,
1991; Barkovich and Liao, 2001; Bongaerts et al., 2001; Cameron and Chaplen, 1997; Cameron
and Tong, 1993; Keasling, 1999; Li and Vederas, 2009; Tyo et al., 2007; Stephanopoulos and
Sinskey, 1993). One of the primary host organisms for this purpose has been Escherichia coli,
because of its wide range of growth substrates and the powerful molecular biological tools
available for its manipulation (Cameron and Tong, 1993; Feist et al., 2010; Leuchtenberger et al.,
2005). Because many of the desired metabolic products are end or intermediate compounds of
the central carbon metabolic network, it has become one of the most studied and well understood
of the biochemical pathways. Glucose, the main network input, is not only an excellent fuel but
also a remarkably versatile precursor, capable of supplying a vast array of metabolic
intermediates for biosynthetic reactions. Glucose is oxidized via two major paths - (i) through
glycolysis to generate ATP and metabolic intermediates, or (ii) through the pentose phosphate
pathway to yield ribose 5-phosphate for nucleic acid synthesis and NADPH for reductive
biosynthetic processes. For most eukaryotic cells and many bacteria living under aerobic
conditions, pyruvate produced by glycolysis is further oxidized to H20 and CO 2 via the
tricarboxylic acid (TCA) cycle, in the process generating significant energy in the form of ATP
(Nelson and Cox, 2008). Twelve well-known precursor metabolites serve as branch points from
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the central carbon metabolic network to generate biomass, and nine of them sit in the glycolysis
and pentose phosphate pathway (Neidhardt et al., 1990). In order to design and predict
productive modifications to this complex network, considerable effort has been put into
developing a quantitative understanding and mathematical description of central carbon
metabolism. Several mathematical models of various types have been developed and applied
over the past few decades, including flux balance analysis (FBA) and ordinary differential
equation (ODE) models (Burgard et al., 2003; Chassagnole et al., 2002; Edwards and Palsson,
2000; Pramanik and Keasling, 1998; Schmid et al., 2004; Usuda et al., 2010;Vital-Lopez et al.,
2006).
The flux balance form is one of the most widely used model types in the field of metabolic
engineering. It is based on the assumption that metabolic transients are more rapid than both
cellular growth rates and dynamic changes in the organism's environment (Stephanopoulos et al.,
1998; Varma and Palsson, 1994). In this view, the metabolic fluxes are considered in quasi-
steady state relative to growth. A useful feature of metabolic flux models is the relatively modest
requirements necessary in terms of specific information regarding biological mechanism. Only
three types of information are required: a list of chemical reactions with their stoichiometry; flux
constraints, such as a maximum rate for each reaction (Vnax); and specification of feeds and
metabolic demands (Kauffman et al., 2003; Stephanopoulos et al., 1998; Varma and Palsson,
1994). For the E. coli metabolic network, this information can be readily acquired from existing
literature and databases, which makes it relatively straightforward to build, although the Vmax
information is less certain. However, the steady-state condition usually leads to an
underdetermined set of equations indicating a continuous space of acceptable solutions. In
general, a unique solution is obtained by optimizing a metabolic objective function, such as
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maximizing biomass production on the assumption that evolution would favor such solutions.
Other approaches, like minimization of metabolic adjustment (MOMA), have also been
suggested, where it is assumed that metabolic fluxes in a knock-out strain undergo minimal
redistribution with respect to the flux configuration of the wild type (Segre et al., 2002). Thus,
FBA can be defined as a linear programming problem with a set of constraints. The constraints
are typically upper and lower flux bounds that define the space of allowable distributions, and
can include bounds obtained from different carbon sources and limited oxygen supply to
simulate environmental conditions (Orth et al., 2010). This construction allows FBA calculations
to proceed very quickly even for large networks and makes FBA models attractive for genome-
wide modeling. FBA has been widely used to model large-scale E. coli metabolic networks,
where several successes have been reported in predicting experimental growth rates under
different environmental and growth conditions (Edwards and Palsson, 2000; Edwards et al., 2002;
Segr& et al., 2002). However, failure to incorporate gene regulatory events and to account for
toxic intermediate build-up has led to discrepancies between model results and experimental
observations. In addition, FBA assumes consistency between the mathematical objective
function and the evolutionary objective. If untrue, the optimal FBA solution may not correspond
to the observed flux distribution in the cell (see review: Edwards et al., 2002). Yet, this condition
becomes problematic for mutant strains, in which evolution may not have achieved optimality.
Therefore, the predictive ability of FBA can be limited, especially for mutant strains with gene
knock-outs. Moreover, the detailed dynamic behavior of the network and the metabolite
concentrations are also not captured by FBA models, although they may not be necessary for
successful metabolic engineering.
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In contrast to the steady-state nature of FBA models, in recent years ordinary differential
equation (ODE) models have started to attract attention as dynamic models of metabolic
networks. Two variants of ODE models have been reported that differ in the types of rate laws
used - the aggregated rate law (ARL) model and the mass-action rate law (MRL) model. ARL
modeling simplifies the description of a single enzymatic step by aggregating the elementary
steps associated with a specific mechanism into a single reaction, where the rate becomes a
sometimes complex and very non-linear function of the species concentrations involved (Lee et
al., 2006; Liao et al., 1996; Tzafriri 2003). The rate formulae are usually derived from mass-
action laws with certain assumptions (e.g., quasi-steady state) or acquired as empirical equations
from the literature. A particularly useful ARL model for the E. coli central carbon network was
presented by Chassagnole et al. (2002). The model covers both glycolysis and the pentose-
phosphate pathway, and it is composed of 30 enzymes and 17 metabolites (Figure 1). The
aggregated reactions and their rate parameters were acquired from published literature and
databases. The model was validated with measured metabolite concentrations under transient
conditions and captures experimentally observed dynamics of metabolite concentrations.
Here we present a new mathematical model for the E. coli central carbon metabolic network.
The model is based on the Chassagnole et al. (2002) ARL model, but we recast it as an MRL
model and re-fit the parameters to additional data. In contrast to ARL, MRL models represent
enzyme reactions with a series of elementary reactions and express the reaction rate with rate
laws consisting of only second-, first-, and zeroth-order reactions. The MRL model can be
mechanistically more accurate, does not require a quasi-steady state assumption, and could be
valid over a wider range of concentrations and conditions. The general formulae of the MRL
model can be expressed in Kronecker form as
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-~ = AM'b + A X X® + B(1 )i- + BU~i 0x~ k
dt
where X is a vector of dynamic species concentrations in the network as a function of time t; Ui is
a vector of network input concentrations that are externally controlled and not evolved by the
model; 20x represents a vector Kronecker product, which is a column vector containing all
possible pair-wise combinations of the species concentrations; Ui®X is a column vector
containing all pair-wise combinations of species and network input concentrations; AM, A
BM, and BC2 ) are the corresponding coefficient matrices, the entries of which are the first- and
second-order rate constants, separately; and k contains zeroth-order rate constants. As all the
reactions in the MRL model are elementary reactions, the species vector contains not only the
metabolites and enzymes, but also the different intermediate complexes between metabolites and
enzymes. Each species participates in only a small set of elementary reactions; thus, the
coefficient matrices are sparse. This ODE-type model can be integrated numerically by a variety
of means to acquire the concentrations of all species as a function of time; long-time solutions
approach the steady state of the system. In addition to its mechanistic realism, which could make
it applicable across broad sets of conditions, the simple and standard Kronecker mathematical
representation provides an opportunity to develop standard and general software to study this
type of model.
Both the ARL and MRL forms of ODE models can simulate network dynamics and provide
both transient and steady-state information on metabolite concentrations, in contrast to FBA
models. ODE models tend to have one or a very small number of steady states, eliminating the
need for biomass maximization or MOMA assumptions as with FBA to reach a unique steady-
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state solution for a given glucose input. It was reported that if unconstrained, the space of steady
states by both FBA and ODE models is the same, but constraints of parameter range can be
readily mapped into kinetically feasible regions of the solution space of ODE models that is not
easily transferable to FBA models (Machado, et al. 2012). However, ODE models require
significant knowledge in the form of kinetic parameters, enzyme levels, and mechanistic
formulae for enzyme reactions. MRL formulations avoid the quasi-steady state assumption of
ARL ones. Moreover, ARL models require knowing the lumped enzyme reaction rate formulae,
which in theory can be obtained based on physical mechanism but are often acquired as
empirical equations. This can complicate incorporation of new enzyme reactions or regulation,
such as inhibitors or activators, which may require new lumped formulae to reactions affected.
MRL formulations, however, because of their mechanistic nature, are generally straightforward
to augment with inhibition and regulation when known.
We built out initial MRL model for E. coli central carbon metabolism from the Chassagnole
et al. (2002) model by expanding each aggregated enzyme reaction to expose the intermediate
elementary steps with their associated rate constants. The overall MRL model was then fit to the
Chassagnole et al. model so that the two models produced essentially identical rates for each
enzyme as a function of substrates. This initial model was successful at matching trajectories
from the Chassagnole et al. model. The two models showed similar behavior for the wild-type E.
coli network; interestingly, though, they started to diverge in behavior for enzyme knock-outs.
Next, this initial MRL model was improved by refitting to a combination of synthetic data
produced from the ARL model and newer experimental data from knock-out strains (Ishii et al.,
2007). In this refitting, rather than produce a single model, we produced a collection of models
that are similarly good fits to the data. This ensemble provides an estimate of uncertainty in the
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parameters fit and in the predictions made. MRL models tend to have a greater number of
adjustable parameters than ARL models, which provides the potential for underdetermination
and overfitting. Here that possibility was minimized by using the ARL model to produce a
substantial number of data points such that the MRL parameters were fit to an overabundance of
data, but non-identifiability is not ruled out.
One of the most appealing and challenging goals of metabolic engineering is to design more
efficient biological systems for industrial use. The mathematical model ensemble built here
provides a foundation for such rational design studies. In order to propose metabolic engineering
changes to the E. coli central metabolic network to produce valuable metabolites, we introduced
an optimization framework, optModulation, for the MRIL model. The approach identifies and
qualifies metabolic improvements. The proposed optModulation scheme was tested by
determining optimal genetic manipulation strategies to maximize a pre-defined reaction flux,
namely, aromatic amino acid production.
Over the past 5 years the global market for fermentation amino acid products has increased
more than 40%, but the efficiency of aromatic amino acid production, particularly tryptophan, by
fermentation remains low (Ikeda, 2003; Leuchtenberger et al., 2005). One difficulty in
tryptophan overproduction is to properly balance the supply of its three precursors. In E. coli, the
production of 1 mole of any aromatic amino acid starts with combining 1 mole of erythrose 4-
phosphate (E4P) with 1 mole of phosphoenolpyruvate (PEP) to form a common precursor
chorismate. In addition, 1 mole of PEP and I mole of serine are further consumed in the pathway
from chorismate to tryptophan (Ikeda, 2006; Nelson and Cox, 2008). Different strategies have
been attempted to modify either the common pathways or the tryptophan branch by metabolic
engineers (see review: Ikeda, 2006). Using the model ensemble, we identified complexities in the
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pentose phosphate pathway such that the direction of flux through this bi-direction loop strongly
affects the choice of manipulation strategies for overproducing aromatic amino acids. The results
of this study also predict that balancing the precursors for tryptophan could be beneficial for its
overproduction.
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2.2 Modeling
2.2.1 Mass-Action Rate Law Model
The ARL model built by Chassagnole et al. (2002) provides a good reference model from
which to generate a more comprehensive MRL model for the central carbon metabolic network
(Figure 1). Foundational work by King and Altman (1956) and Cleland (1963) provides a bridge
between the elementary rate constants of MRL models and the more abstract parameters of ARL
models. The authors of those studies describe a graphical method to derive the steady-state rate
law from a system of elementary reactions. This method has since been developed into a formal
algorithm (Cornish-Bowden, 1977) and is available as a web tool (Kuzmic, 2008). To convert
the Chassagnole et al. ARL model into an MRL model, we constructed elementary reactions for
each enzyme in the ARL model based on the enzyme mechanisms reported in Chassagnole et al.
Next, a steady-state rate law was derived using the King-Altman method. Then, we optimized a
preliminary set of MRL parameters by fitting the rate versus substrate concentration curves
calculated from the King-Altman steady-state rate law for MRL model to those simulated from
the ARL model. This process was carried out for each enzyme in the ARL model. The objective
function for the fitting, Gchassagnoie, was similar to a chi-square metric, being a sum of squared
differences weighted by the inverse variance.
2
Gchassagnoe= rpred,chassagnole - rdatachassagnole
chassagnoagnle
rdata,chassagnole Cdata,chassagnole
In this objective function, rdaaa,chassagnoL is the steady-state reaction rate at given species
concentrations based on the ARL model, and rpred,chassagnole is the steady-state reaction rate at the
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same species concentrations based on the King-Altman method calculated from the MRL model.
The range for the species concentrations used in the fitting varied for different metabolites and
different enzyme reactions, but generally spanned from 0.01 mM to 100 mM. Typically 1,000-
27,000 points were used to fit each enzyme; the points were equally spaced in the logarithm of
the concentration. Grids of species concentrations were created and used for reactions involving
more than one species in the rate law. The optimization was done using the fmincon function
in MATLAB (version 2008b; The MathWorks, Inc.; Natick, MA).
2.2.2 Network Topology Augmentation
The initial MRL model converted from the Chassagnole et al. model was updated to include
several important enzymes and metabolites in the glycolysis and pentose phosphate pathways.
To make the network model more comprehensive, the KEGG database (8/6/2009; Kanehisa and
Goto, 2000) was used to select model additions. The complete list of changes is given in Table 1,
and some are described in the following paragraph.
A number of enzymatic conversions in E. coli are carried out by multiple isomers with the
same general activity but with potentially different rate parameters and cellular concentrations.
The original Chassagnole et al. model used a single enzyme to represent such instances. Because
of our interest in designing meaningful genetic variants for metabolic engineering, we
augmented the topology to include ten separate pairs of isomers where previously ten individual
enzymes represented the biochemistry. This expansion led to locally parallel routes, instead of a
single path, which makes it possible to design knock-out mutant strains that only partially shut
down a pathway. In addition, three new enzyme reactions (due to the enzyme products of the
genes pgl, edd, and eda) and 2 new metabolites (gluconolactone-6P and KDPG [2-keto-3-deoxy-
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6-phosphogluconate]) were also added to the network. The edd and eda reactions represent the
Entner-Doudoroff pathway, which is an alternate route that catabolizes glucose to pyruvate. It
has been shown that the accumulation of KDPG in bacteria is correlated with an immediate and
significant decrease in growth. In fact, the gene product of eda has been considered a target for
the development of new bacteriostatic or bactericidal drugs (Braga et al., 2004). In the
Chassagnole et al. model, two constant fluxes are used to model the production of G3P and PYR
from tryptophan synthesis. The cellular concentration of tryptophan and its precursors could be
dramatically affected by metabolic engineering manipulations, which would not be properly
reflected by this constant flux treatment. We thus elected to make these fluxes dependent on the
available concentrations of precursors. Specifically, we assumed that all fluxes that produce the
aromatic amino acid precursor chorismate are converted to tryptophan, and ignored the
production of phenylalanine and tyrosine. Two enzyme reactions based on TrpSynthl and
TrpSynth2 were added to model this process of generating tryptophan and thus directly linked to
G3P and PYR dynamically.
The enzyme reaction mechanisms were preserved for enzymes in the Chassagnole et al. model;
whereas those of added enzymes were determined based on the BRENDA database (8/6/2009)
(Scheer et al., 2010). Most of the isomers share a similar mechanism with their parallel enzymes,
but some isomers (e.g., PFKB) do not show the same cooperative interaction with their ligand or
are not affected by inhibitors. Additionally, some isomers do not equally share activity; instead,
one of the parallel isomers accounts for most of the enzyme activity, either due to rate constants
or concentration.
The main input of the model is the supply of glucose. Chassagnole et al. modeled supply as a
constant extracellular concentration in the starting model. Because most experimental data about
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metabolic reactions are based on chemostats in which glucose flows in and is removed from the
reaction vessel as a flux with a specific flow rate, we changed the constant glucose feed into
dynamical flux reactions in the model. After all of these changes were made, the new model
consists of 43 enzyme reactions, 211 species, and 263 free kinetic parameters. Figure 1 depicts
the overall topology of the model. The model is available as supplementary material.
2.2.3 Parameter Fitting
We adopted a dual strategy for parameter estimation. One aim was to select parameters for our
MRL model so that the dose-response curve of the enzyme reaction rates as a function of
metabolite concentrations matched those from the original model of Chassagnole et al. (2002).
Simultaneously our second aim was to select parameters that produced results matching a more
recent experimental data set published by Ishii et al. (2007), containing normalized steady-state
concentrations for 12 of the 18 metabolites in the model for wild-type E. coli K- 12 strain
BW25113 as well as for 22 variant strains each with one enzyme knocked out. The actual steady-
state concentrations were recreated from these normalized data by re-scaling them so that the
wild-type metabolite concentrations match those calculated from the Chassagnole et al. model
with the dilution rate and glucose feed the same as in the Ishii et al. experiments.
Candidate parameter sets that fit both the Ishii et al. measurement data and the Chassagnole et
al. enzyme reaction rates were generated by fitting to a weighted component objective
G(w) containing two terms, one representing deviation from the Chassagnole et al. rates and the
other deviation from the Ishii et al. data.
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2G (w) = w - rpredchassagnole - rdata,chassagnole
rdata,chassagnole (data,chassagnole
+ Xpredishii - Xdata,ishii
Xdataishii Jdata,ishii )
The first summation was the same as described for Chassagnole et al. model fitting. The second
summation represented sum-of-squares fitting of the predicted chemical concentrations from the
model to the measured Ishii et al. data, normalized by the variance of the measurement data. To
generate initial parameters for this dual fitting, 1000 parameter sets were generated based on the
optimized parameters from only fitting the Chassagnole et al. model. For each parameter set, a
random number of parameters up to 50% of all parameters were selected and replaced by a
random number based on a Gaussian distribution with mean as the value from Chassagnole et al.
fitting and the standard variation as one third of the log of the largest parameter value allowed
(i.e., 10"). The weighting factor w played an important role in the optimization. Small values
caused the optimization to focus only on optimizing the Ishii sub-objective with little control on
the Chassagnole sub-objective; whereas for large values the fitting of the Chassagnole sub-
objective would dominate the Ishii sub-objective. Rather than attempting to determine an ideal
balance between the fitting of Chassagnole and Ishii sub-objectives, we carried out a series of
optimizations with a range of values for w chosen that spanned 0.05 to 20.
This collection of optimization with various weights swept out a pareto optimal frontier
(Figure 2A). Each point represented the result of a single optimization for a particular value of w.
Moving along the frontier improved the fit to one part of the objective and degraded the fit to the
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other. Thus, the frontier represented different tradeoffs achievable. Naturally, a higher weight on
the Chassagnole part of the objective led to a better fit to that sub-objective and a worse fit to the
Ishii sub-objective. Examination of the fitting behavior for each of the 44 points on the frontier
demonstrated rather good fits to both sub-objectives. It is a somewhat arbitrary choice to select
the best fitted model from the pareto optimal frontier. Here we selected the blue point in Figure
2A as our fitted model and the basis for local sampling in parameter space; the red points were
also used but no further sampling around them was performed.
2.2.4 Model Ensemble
A potential problem for detailed mechanistic models is the combination of a high dimensional
parameter space and limited data available for training; this is especially an issue for mass-action
models due to their large number of parameters. Although there may be a set of optimal
parameters, wide ranges of parameters surrounding the optimum may fit the available data
almost as well. Such is the case here for our model fit to the Chassagnole et al. model and Ishii et
al. data. Moreover, due to measurement error, a parameter set with a somewhat disadvantaged
objective value may be closer to the true parameter values. To improve the reliability of model
predictions, we generated a model ensemble that represents the parameter uncertainty, and used
the ensemble to make predictions.
Latin hypercube sampling (LHS) (McKay et al., 1979; Stein, 1987) was used to collect
candidate parameter sets in order to distribute a reasonable number of samples over the
parameter space. In LHS all the parameters were assumed to follow a multivariate Gaussian
distribution, with mean values as the best fitted parameter values from the previous session and a
covariance matrix as the inverse of a modified Fisher information matrix calculated from the best
50
fitted values. The Fisher information matrix was modified by replacing the eigenvalues smaller
than an arbitrary cutoff of 58.1 with this cutoff, which corresponds to approximately a 30%
change in the parameter values along the eigendirections. This choice retained 61 original
eigenvalues out of the 263 and removed the remaining flat eigendirections that could have
caused oversampling of invalid regions. 20,000 parameter set samples were drawn using LHS
and 85 of them fell within the tolerance level as fitting well to both the Chassagnole et al. model
and the Ishii et al. data. In order to reduce the bias effect of the arbitrarily chosen best fitted
model, all 44 frontier samples were also included into the final ensemble, giving 129 sub-models
in the ensemble.
2.2.5 Model Manipulation
An optimization framework was applied to the model ensemble to identify strategies leading
to enhanced aromatic amino acid production. The objective function was the aromatic amino
acid production rate from the reaction catalyzed by the enzyme DAHPS complex from the two
substrates PEP and E4P. The set of strategies considered consisted of enzyme knock-outs, in
which an enzyme activity was completely removed from the model, as well as enzyme over- and
under-expression (termed "expression change" here) spanning a range from ten times to one-
tenth the unperturbed concentration. All combinations of single, double, and triple enzyme
knock-outs as well as all combinations of one and two enzyme expression changes were
constructed and studied. If one enzyme concentration in a two enzyme expression-change
strategy was suggested to be the value of the lower bound (one-tenth the unperturbed
concentration), a knock-out of that enzyme plus an expression change of the other enzyme was
also studied.
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The effect of pure knock-outs, whether single or multiples, was studied by simulating until a
steady state was reached and evaluating the objective function in the steady state. The effect of
perturbations that included one or more expression-changed enzymes was studied by optimizing
to find the combination of levels of modified enzymes leading to the maximum objective. The
optimization was done using the f mincon function in MATLAB (version 2008a; The MathWorks,
Inc.; Natick, MA). These evaluations were carried out individually on each sub-model in the
ensemble. For the case of enzyme expression changes, the level of modification was taken as the
median across all sub-models in the ensemble, and each sub-model was re-simulated with this
value to re-evaluate the objective in order to reflect the production improvement for the
ensemble. For both knock-out-only and enzyme expression-change perturbations, the score of a
strategy was taken as the average production improvement ratio of perturbed strain against wild-
type strain over all sub-models in the ensemble, and the support rate of a strategy was defined as
the percentage of sub-models showing any improvement (greater than 0.1%) over the objective
in the unperturbed network.
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2.3 Results and Discussion
The E. coli central carbon metabolism model of Chassagnole et al. (2002) was converted to
mass-action form, augmented with additional enzymes, and reparameterized using both the rate
behavior from the starting model and experimental data from Ishii et al. (2007; see MODELING).
The resulting model provided an excellent fit to the training data (Figure 2). The value of the 210
computed steady-state metabolite concentrations was within 2 fold of the values obtained by
Ishii et al. (2007), with an average difference of roughly 50% (Figure 2B). Simultaneously, most
of the enzyme reactions had a perfect or near perfect fit to the corresponding Chassagnole et al.
reactions (Figure 2D), with only a few reactions fitting worse but still reasonably (the worst fits
are shown in Figure 2C). From this single parameter set, an ensemble of 129 models was
constructed that fit the data essentially equally well and that differed from each other only in
their parameters (see MODELING). Each member of the ensemble was an excellent fit to the
training data and together the ensemble represented the parameter uncertainty inherent in
underdetermined biochemical models; in the work here, the ensemble was used to compute a
representation of prediction uncertainty.
2.3.1 Knock-out strategies reveal the complexity of the pentose phosphate pathway
Each of the 129 models in the ensemble was explored using combinations of one, two, or three
gene knock-outs to identify variants with increased production of aromatic amino acids. The
results for single knock-outs are examined here first and the model ensemble shows strong
consensus for nearly all of the knock-outs (Figure 2). Each knock-out was classified by
computing a productivity factor, which is the ratio of the steady-state aromatic amino acid
production rate with and without the knock-out. The categories used were reduced (<0.8 fold,
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blue), neutral (0.8-1.2 fold, yellow), marginally increased (1.2-1.5 fold, orange), and increased
(>1.5 fold, red). Most of the knock-outs were predicted to lead to reduced or neutral production
in each of the 129 models. A few gene knock-outs were predicted to lead to increased production
in all (ppc and pykF) or most (gipat, pgm, and rpe) models. Even when most but not all models
predicted increased production, the dissenting models usually predict marginally increased or
neutral production. Interestingly, rpe is the exception; most models expected increased
production, but thirteen predicted reduced production. Moreover, the talB knock-out has
complementary behavior; most models predicted reduced production, except the same thirteen
that predicted an enhancement. Finally, a minority of models predicted enhanced production for
rpiA and rppk knock-outs, with the remaining models predicting neutral or marginally increased
production in all but two cases. Interestingly, the two most strongly predicted knock-outs for
improved yield (ppc and pykF) have been tested and proved effective experimentally by several
research groups (Backman, 1992; Gosset et al., 1996). In particular, a pykF and pykA double
knock-out in E. coli PB 103 strain resulted in a 3.4-fold increase in carbon flux to aromatic
biosynthesis (Gosset et al., 1996), which is very similar to the predicted 4.03-fold improved
aromatic amino acid production by our ensemble model.
Analysis of steady-state fluxes in all 129 models of the ensemble was carried out to understand
the source of computed improvements in aromatic amino acid synthesis (see Figure 4). The gene
products ofppc and pykF are both responsible for fluxes away from the metabolite
phosphoenolpyruvate (PEP), which is one of the two precursors of aromatic amino acid synthesis.
Steady-state flux results indicated that knocking out either gene singly increased the steady-state
amount of PEP significantly (average 14.0 and 2.1 fold, respectively) as well as the flux into
aromatic amino acid synthesis (average 55.9 and 4.0 fold, respectively). On the other hand, the
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genes rpe, rpiA, and talB are all located in the pentose phosphate pathway and thus may be
responsible for increasing the steady-state concentration of erythrose-4-phosphate (E4P), the
other precursor of aromatic amino acid synthesis, and the corresponding flux. Knocking out the
gene rpe, rpiA, or talB did not affect steady-state PEP concentration significantly, but did
increase E4P concentration for all but thirteen models, 114 models, and thirteen models,
respectively. The thirteen models showing decreased E4P concentrations with rpe knock-out or
increased E4P concentrations with talB knock-out were the same thirteen models mentioned
above that showed improved aromatic amino acid production. The other three single knock-outs
predicted to increase aromatic amino acid synthesis in some or most of the models (pgm, g1pat,
and rppk) terminate carbon fluxes flowing away from the central pathway toward biosynthesis;
knocking-out each one individually should also direct more carbon into PEP and E4P. The
results indeed show that these three knock-outs moderately increase the steady-state
concentrations of both PEP and E4P, as well as the flux toward aromatic amino acid synthesis.
Results above show that knocking out the pentose phosphate pathway genes rpe, rpiA, and
talB can increase steady-state E4P concentration and thus aromatic amino acid synthesis rates.
However, it is still not clear why these knock-outs increase E4P concentration, partially due to
the complex topology of the pentose phosphate pathway. It is particularly surprising to see that
knocking out the gene talB, the product of which is the immediate enzyme that generates E4P, is
able to increase E4P concentration and aromatic amino acid synthesis in some models. A more
detailed steady-state flux analysis was thus carried out to understand the carbon flow in the
pentose phosphate pathway. Interestingly, the results indicate two distinct wild-type steady-state
flux patterns for the pentose phosphate pathway among the models - a clockwise flux and a
counter-clockwise flux (Figure 5). In the wild-type case (black lines), most models have a carbon
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flow direction from metabolite Ru5P to X5P/R5P, to S7P/G3P, to E4P/F6P, and to F6P/G3P
(clockwise flux); whereas thirteen models have a reversed flux direction for the enzymes RPE,
TKTa/TKTb, and TALa/TALb (counter-clockwise flux). Previously we noted that the rpe
knock-out was predicted to increase aromatic amino acid synthesis in all but thirteen models;
whereas the talB knock-out had the complementary behavior. Further investigation revealed that
the models in which the rpe knock-out showed improvement corresponded to the clockwise flux
models, and those for which the talB knock-out showed improvement corresponded to the
counter-clockwise flux models. The steady-state flux analysis in Figure 5 showed that in
clockwise flux models the rpe knock-out (red lines) reduced the carbon flux from metabolite
Ru5P to E4P (tktA/tktB-S7P and talA/ta/B flux) and induced a reversal of the tktA/tktB-F6P flux,
which corresponds to a switch from a clockwise pentose phosphate pathway flux pattern to a
counter-clockwise pattern. In the counter-clockwise flux models, the talB knock-out (green lines)
terminates the flux flowing away from the metabolite E4P and thus directs more flux toward
aromatic amino acid synthesis. Putting the knock-out strategies into the "wrong" flux pattern
model results in a decrease of aromatic amino acid synthesis. Interestingly, Ikeda (2003)
suggested a possible theory of two-way flux for the effect of manipulating the pentose phosphate
pathway in his review of amino acid production. He suggested that a clockwise flux from
glucose-6-P to ribose-5-P and then to E4P helps the accumulation of ribose-5-P and thus
increases histidine production, whereas a counter-clockwise flux increases E4P concentration
and improves aromatic amino acid production. This theory is consistent with our results from
ensemble modeling, namely that there could be two distinct flux directions in the pentose
phosphate pathway and the conversion from clockwise to counter-clockwise flux increases
aromatic amino acid production. The results also indicate that the choice of knock-out strategies
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for aromatic amino acid overproduction may depend on the particular wild-type flux pattern of
the pentose phosphate pathway under the particular growth conditions. On the other hand,
experimental tests on talB and rpe knock-outs will provide insights for eliminating inappropriate
models from the ensemble.
For a defined system, the steady-state concentrations are usually determined by the parameters.
However, our model topology only covers a subset of the whole cell system, and there is a
possibility of having a different steady state for the whole system. In order to determine whether
the two-way flux pattern was caused by intrinsic variance of the parameter sets or extrinsic
differences of the metabolite steady state, the tkt flux generating F6P and G3P was recalculated
for each model using the wild-type steady-state concentrations from all models. Only the results
of the 44 frontier models are shown in Figure 6, as the LHS models have similar behaviors.
Results show that there is one model that always has a clockwise pattern for all steady-state
concentrations tested, and there is another model that always has the counter-clockwise pattern
for all steady states. The rest of the models can have either the clockwise or the counter-
clockwise pattern depending on which steady state they experience, although some models may
have a bias. This indicates that both the intrinsic parameters of the model and the environmental
species concentrations matter for determining the flux direction in the pentose phosphate
pathway.
When double and triple knock-outs were included, many more options were identified that
improved aromatic amino acid production. Multiple knock-outs also showed greater increases in
the production rate; the model, unaware of limitations on metabolism outside of the central
carbon pathway, claimed to have found a 245-fold improvement with the best performing double
knock-out and a 410-fold improvement with the best performing triple knock-out, compared to
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67 fold for the best single knock-out. Large variation was observed in the support rate across
different strategies, where a strategy can receive between 100% and 0.8% support from the sub-
models. (The support is defined as the fraction of models in the ensemble that predict an
improvement in production, and thus serves as a proxy for level of consensus in the result.) This
variation reflects differences and parameter uncertainty among sub-models. Interestingly, a
combination of the talB knock-out discussed above and one of the zwf pgl, or gnd knock-outs
increases the support rate of the model ensemble to 100%; whereas a single talB knock-out alone
received a positive vote from 13 of the 129 sub-models. Further investigation showed that an
additional knock-out of zwf pgl, or gnd helped reverse all clockwise models to counter-
clockwise models, so that the talB knock-out, which blocked carbon from leaving E4P in
counter-clockwise models, worked for all the sub-models and reached an average of 6.7-fold
increase for aromatic amino acid production. This result indicates that multiple knock-outs may
identify more reliable strategies despite the parameter uncertainty, and those strategies may lead
to higher success rates in experimental tests.
2.3.2 Up and down regulation allow new engineering strategies to improve aromatic
amino acid production
Rather than using only knock-outs, next we considered combinations of different genetic
modifications. Specifically, we allowed up or down regulation or knock-out of up to two
enzymes, and we optimized for aromatic amino acid production (see Methods). The upper and
lower bound on the enzyme gene expression changes were selected based on examples from the
literature and common laboratory practice. Some research groups report enhancing the activity of
the glycolytic enzymes PPS and aldolase by 10-15 fold (Babul et al., 1993; Patnaik and Liao,
1994). The general practice for enzyme regulation in research laboratories is approximately up to
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a 10-fold enhancement or reduction (Alper et al., 2005). For the current study we thus chose
expression changes of up to 10 fold in either direction. To increase the reliability of candidate
strategies identified, we further required consensus among sub-models - at least 80% for single
modifications and 90% for double modifications. Additionally, double modifications were
required to have a higher production rate than both of the corresponding single changes.
Strategies identified based on these criteria are listed in Table 2. Results of single and double
knock-outs, one knock-out plus one up or down regulation, and two up or down regulations are
incorporated together to make this table comprehensive.
Compared to knock-out-only strategies, the inclusion of enzyme up or down regulation allows
for new modes for increasing aromatic amino acid production. A total of 37 strategies were
identified that involved up regulation of at least one enzyme. Many of these strategies involved
overexpression of dahps alone or in combination with a change to another enzyme, leading to
modeled production increases of 9 fold to 220 fold. The gene product of dahps in the model
represents a lumped enzyme that converts a molecule of erythrose-4-phosphate (E4P) and one of
phosphoenolpyruvate (PEP) to shikimate-3-phosphate (S3P), which combines with another
molecule of PEP to form, in two enzymatic steps, chorismate, the common precursor to aromatic
amino acids (Figure 1). While it is intuitive that dahps is on the synthetic pathway and thus could
be limiting, there are many enzymes (e.g., trpSynth1, trpSynth2) on the direct synthetic pathway,
and the model has done something significant and non-obvious in identifying this enzyme group
as limiting. To what extent dahps plays as a limiting factor depends on its kinetic parameters. If
we increase the kcat and ko, of dahps binding E4P and PEP by 100 fold, any further increase of
dahps concentration will not increase the production rate of aromatic amino acids. In other words,
dahps is no longer the rate limiting factor under this arbitrary condition. In fact, several research
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groups have overexpressed the collection of individual enzymes represented by dahps and
observed production improvements that form the basis for industrial production strains (Azuma
et al., 1993; Berry, 1996; Chan et al., 1993). Other enzymes whose overexpression increases
aromatic amino acid synthesis were distributed throughout glycolysis (pts, fbaB, tis, pgk, gpmB,
pykF, and pfkA) and the pentose-phosphate pathway (rpiB, tktB, and talB), indicating other
limitations as well. Interestingly, many of the overexpressed enzymes did not optimize to the full
10-fold overexpression bound, but rather converged at an intermediate value. Most of these cases
involve enzymes in the pentose phosphate pathway (e.g., tktB, talB, and rpiB) or the triangle
region before G3P (e.g.,.fbaB and tis), where further overexpression of the enzymes beyond the
optimal value starts to decrease the production rate. This indicates the complexity of the two
regions in the network and the importance of the fine-tuned enzyme optimization strategies.
The knock-down results provide an interesting comparison to the knock-out results. In some
cases, a complete knock-out further enhances productivity compared to partial knock-down,
including ppc (10-fold knock-down increases production 45.1 fold; knock-out increases
production 66.6 fold). However, in a number of cases, a partial knock-down results in greater
productivity than a complete knock-out, including gapA (10-fold knock-down increases
production 35.9 fold; knock-out has zero production due to complete depletion of PEP, which
makes sense given the topology of Figure 1). The existence of multiple isomers with the same
activity provides a convenient way to partially knock down a pathway by knocking out only one
of the parallel isomers.
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2.3.3 Engineering strategies that rebalance carbon fluxes between glycolysis and pentose
phosphate pathway lead to improvement of aromatic amino acid production
A group of high-performance strategies involving down-regulating enzymes or knocking out
isomers located downstream of G3P in the glycolysis pathway (gapA, pgk, gpmA, and eno) were
observed, which are not intuitive as these enzymes directly lead to the generation of the
precursor PEP for aromatic amino acid production. A further examination shows that the steady-
state concentration of PEP is approximately 13 fold higher than that of E4P in wild-type models
(Figure 7A). A 10-fold knock-down of gapA reduced the steady-state concentration of PEP to
91.9% while increasing that of E4P to 3.9 fold (PEP to E4P ratio is 3.2); the corresponding
aromatic amino acid production rate was increased to 13.6 fold. A combination of a 10-fold
knock-down of gapA and a 10-fold knock-down of gpmA decreased the concentration of PEP to
28.0% while increasing the concentration of E4P to 7.0 fold (PEP to E4P ratio is 1.4); and the
corresponding aromatic amino acid production rate was further increased to 33.4 fold (Figure
7A). On the other hand, a combination of tktB and ppc knock-outs corresponding to an increase
of PEP concentration and decrease of E4P concentration (PEP to E4P ratio is 1243) resulted in a
significantly lower aromatic amino acid production rate (12.1% of the wild-type level). The
production of 1 molecule of an aromatic amino acid requires I molecule of PEP and I molecule
of E4P - an equal amount of the two precursors. The results above indicate that strategies that
increased the level of E4P to match that of PEP led to significant improvement in aromatic
amino acid production, whereas strategies that increased the discrepancy in the amounts of the
two precursors reduced productivity. This effect can also be seen in Figures 7B and 7C, showing
that a relative ratio of PEP to E4P closer to one resulted in higher aromatic amino acid
productivity.
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Further investigation was conducted to understand the relative sensitivity of aromatic amino
acid production to the concentrations of E4P and PEP. The rpe + rppk + pgm triple knock-out
model and tktB knock-out model had approximately the same level for PEP steady-state
concentrations, but increased E4P steady-state concentration to 7.6 fold and decreased E4P
concentration to 24.0% of the wild-type value, respectively. The corresponding aromatic amino
acid production rate increased to 55.1 fold and decreased to 5.9% of the wild-type level,
respectively (Figure 7A). On the other hand, the triple knock-outs rpe + ppc + talB and pdh +
rpiA + pgl kept E4P levels approximately the same, but either increase or decrease the PEP
steady-state concentration. Interestingly, a 20.5-fold increase in PEP concentration resulted in
only a 1.9-fold increase in the aromatic amino acid production rate (Figure 7A). This indicates
that the E4P concentration has a limiting role under the conditions of this study, and aromatic
amino acid production is much more sensitive to the concentration of E4P than to that of PEP.
The gapA and gapA + gpmA knock-down strategies discussed above reduced carbon flow
through the glycolysis pathway toward PEP and redistributed the carbon flux toward E4P. They
increased the overall production rate significantly by sacrificing some amount of PEP in order to
increase the E4P concentration. Conventionally, metabolic engineers focus more on increasing
one or both of the precursors of aromatic amino acid synthesis, but little attention has been
focused on creating a balance between the two, partially because of the difficulty in identifying
proper experiment strategies. Our results show that the mathematical models we presented here
are capable of identifying the limiting precursor and providing strategies that rebalance the
precursors and efficiently improve productivity.
Unlike the strategies such as ppc knock-out, synth1 knock-out, and g1pat knock-out, which
work by removing a carbon sink and thus directing more carbon toward aromatic amino acid
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production, the rebalancing strategies re-distribute redundant carbon from PEP to E4P and thus
do not require increased carbon supply to enhance productivity. A combination of these two
types of strategies resulted in the largest computed improvement of aromatic amino acid
production.
The synthesis of tryptophan, an aromatic amino acid, also requires serine as an additional
precursor in the path that branches past chorismate. Therefore, strategies that reduce serine
production, e.g. knock-out of the serine synthesis reaction, would not be good candidates for
tryptophan production. We simulated the level of serine production for each strategy in Table 2
and calculated the serine production improvement ratio (see Table 2). If tryptophan
overproduction were the target, the serine production improvement ratio would also need to be
taken into account. All of the strategies reported in Table 2, except for the serine synthesis
reaction knock-out, have a small effect on or negligible reduction of (approximately 10% or less,
if any) the serine production rate.
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2.4 Conclusions
The central carbon metabolic network is one of the most important biological networks in
metabolic engineering, as most of the precursors for primary and secondary metabolites that have
industrial interests are coming from this network. Given the complicated enzyme interactions
and regulations in this network, it is often not straightforward to identify efficient strategies to
optimize the production rates of the target metabolites. Here we presented a mass-action model
ensemble, which incorporated the most up-to-date knowledge about the topology and enzyme
isomers, for the E. coli central carbon metabolic network. The model ensemble includes 129
individual models which have equally good fit to the steady-state data from Ishii et al. and the
reaction rate data from Chassagnole et al. The variations of parameters among different models
thus provide a useful measurement for the impact of parameter uncertainty on model predictions.
An exhaustive optimization search, including single, double, and triple enzyme knock-outs as
well as single and double enzyme over- and under-expressions, was applied to the model
ensemble in order to identify enzyme strategies that can maximize the aromatic amino acid
production rate. The rpe and talB single knock-outs identified through the optimization reveal
the complexity of the pentose phosphate pathway and suggest there could be two natural flux
direction of the pentose phosphate pathway, clockwise direction and counter-clockwise direction.
More importantly, different strategies may be needed to optimize the aromatic amino acid
production, depending on the natural direction of the system. As two precursors are required for
the aromatic amino acid production, it is believed that a balanced precursor level could benefit
the production the most. Non-obvious strategies that help re-partition the carbon fluxes towards
the PEP and E4P precursors were identified by the optimizations. It improves the aromatic amino
acid production without the need to increase the network carbon input. Without the
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computational model ensemble we built, it would be difficult to identify these strategies given
the complexity of the central carbon metabolism. The mathematical model ensemble and the
manipulation tool we built here can be easily extended to study other chemicals of interests that
have precursors from the central carbon metabolic network. With limited data, it is anticipated to
have the capability to provide insightful guidance of experimental designs that optimize the
production yields of the desired chemicals.
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Figure 1. Structure of the central carbon metabolic network model. The red box indicates the glycolysis pathway; the blue box
indicates the pentose phosphate pathway; and the yellow box indicates the aromatic amino acid synthesis pathway. The blue
letters are the terminal products as output of the network. The enzymes and metabolites in red are the modifications made to the
Chassagnole et al model. The aromatic amino acid synthesis pathway (yellow box) was added to the Chassagnole et al. model to
replace the constant carbon flux to G3P and PYR due to tryptophan synthesis.
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Figure 2. A. Pareto optimal frontier. The x-axis is the chi-square objective value of fitting to Chassagnole et al. (2002) rate
formulae, and the y-axis is the chi-square objective value of fitting to Ishii et al. (2007) measurement data. 44 frontier points
were obtained from the optimization by systematically varying the weighting factor w. The blue point indicates the parameter set
that was chosen as the basis for local sampling in parameter space. B. The relative difference of the calculated steady-state
metabolite concentrations to the 210 Ishii et al.(2007) measured steady-state values for the optimal (blue in panel A) model. C,
D. Representative fitting results for the optimal model (red dotted lines) to the Chassagnole et al. model (blue lines); C. (RPPK
reaction) represents the worst fitting reaction and D. (DAHPS reaction) represents a typical fitting reaction.
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Figure 3. Single knock-out results for 129 sub-models. The columns correspond to the 42 single knockouts and the rows
correspond to the 129 sub-models. The data plotted are the ratio of aromatic amino acid production rate for knockouts to that for
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74
I I I I I I I I I I I | I I I I I I I I I I | |
30
25
20
ppc
ppc
300r -
250 -
200 -
150 -
1 00
50
0
ppc
3.5
3
2.5k
2
1.5 k
1
I
I
'I
pykF rpe rpiA taIB pgm gi Pat rppk
f-1
pykF rpe rpiA taIB pgm gipat rppk
I
pykF rpe rpiA taIB pgm gipat rppk
0
3
2.5
2
1.5
1
0.5
0
10
8
6
4
2
0
Figure 4. Steady-state flux analysis on important knock-outs. The top panels (PEP) and middle panels (E4P) show the relative
steady-state concentrations of the knock-out strains to the wild-type strain: the bottom panels show the relative steady-state
aromatic amino acid fluxes of the knock-out strains to the wild-type strain. The box plot indicates the results of the 129 models
in the ensemble, with the middle red line as the median, the edges of the box as the 2 51h and 75th percentiles, the whiskers
extended to the most extreme data points not considered outliers, and the outliers plotted individually.
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Figure 5. Steady-state flux analysis. A. the pentose phosphate pathway. The solid arrow shows the direction of clockwise flux
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Tables
Table 1. The enzyme reaction modification.
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Old enzyme New enzymes Mechanisms
PGIuMu GPMA/GPMB Uni-Uni reversible
R5PI RPIA/RPIB Uni-Uni reversible
Aldolase FBAA/FBAB Uni-Bi ordered reversible
PFK PFKA/PFKB/FBP Uni-Uni irreversible with and without Hill Coef
TA TALA/TALB Bi-Bi ordered reversible
Tka Tka/TKb Bi-Bi ordered reversible
TKb Tka/TKb Bi-Bi ordered reversible
PK PYKF/PYKA/PPSA Uni-Uni irreversible with Hill Coef
G6PDH ZWF/PGL Uni-Uni reversible/Uni-Uni irreversible
EDD/EDA Uni-Uni reversible/Uni-Bi ordered reversible
TrpSynth TrpSynthl /TrpSynth2 Bi-Bi ordered irreversible/Uni-Uni irreversible
Strategies Support E/EO Score Serine Strategies Support E/E Score Serine Strategies Support E/E0  Score Serine
EDD+ PYKA 96.1% KO/KO 1.001 1.00 RPIA 91.5% KO/KO 1.40 0.94 PFKA 100% KO/KO 1.24 1.01
EDD+FBAA 92.2% KO/KO 1.004 1.00 Ru5P 93.0% KO/KG 2.84 0.89 PFKB 100% KO/KO 1.26 1.02
PYKA + FBAA 92.2% KO/KO 1.004 1.00 GPMB 99.2% 10/10 2.93 2.52 RPPK 100% KO/KO 1.30 1.10
PGK + PTS 92.2% 0.1/0.1 1.29 0.97 PFKB 100% KO 1.08 0.96 RPIA 96.9% KO/KO 1.59 1.04
RPIA + GND 99.2% KO/KO 1.78 0.93 TALA 100% KO/KO 1.09 0.96 Synth1 100% KO 1.16 1.07
RPIA + PGL 99.2% KO/KO 1.86 0.94 MetSynth 100% KO/KO 1.09 0.96 G3PDH 200% KO/KO 1.17 1.07
GPMA+ PTS 98.4% 0.1/0.1 3.09 2.43 PPSA 100% KO/KO 1.09 0.96 ZWF 100% KO/KO 1.21 1.09
GPMA + PGM 100% 0.1/KO 5.15 2.82 PYKA 100% KO/KO 1.09 0.96 PFKA 100% KO/KO 1.23 1.02
GPMA+ Ru5P 99.2% 0.1/KO 5.62 2.43 EDD 100% 0 KO/KO 1.09 0.96 PFK8 100% KO/KO 1.26 1.02
TALB+ GND 100% KO/KO 6.24 0.97 FBAB 100% KO/KO 1.09 0.97 RPPK 100% KO/KO 1.31 1.11
TALB + PGL 100% KO/KO 6.39 0.99 FBAA 100% KO/KO 1.09 0.97 Mur 100% KO/KO 1.35 1.13
TALB +ZWF 100% KO/KO 6.67 1.02 G3PDH 100% KO/KO 1.09 0.97 RPIA 96.9% KO/KO 1.59 1.04
G3PDH 100% KO 1.01 1.00 ZWF 100% KO/KO 1.14 0.99 SerSynth 200% KO 1.20 0
TALA 100% KO/KO 1.01 1.00 RPIA 91.5% KO/KG 1.42 0.95 ZWF 100% KO/KO 1.25 0
PPSA 100% KO/KO 1.01 1.00 RPPK 100% KO 1.12 1.04 PFKA 100% KO/KO 1.27 0
EDD 100% KO/KO 1.01 1.00 TrpSynth2 100% KO/KG 1.12 1.04 PFKB .100% KO/KO 1.29 0
PYKA 100% KO/KO 1.01 1.00 TALA 100% KO/KO 1.12 1.04 RPPK 100% KO/KO 1.35 0
FBAB 100% (/1(0 1.01 1.00 PPSA 100% KO/0 1.12__ _1.04 Mur 100% KO/KO 1.39 0
FBAA 100% KO/KO 1.01 1.00 PYKA 100% KO/KO 1.12 1.04 Synth1 100% KO/KO 1.42 0
ZWF 100% KO 1.04 1.02 EDD 100% KO/KG 1.12 1.04 RPIA 98.4% K/KO 1.64 0
MetSynth 100% KO/KO 1.04 1.02 FBAB 100% KO/KO 1.13 1.04 Ru5P 90.7% KO/KO 2.83 0
TALA 100% KO/KO 1.04 1.02 FBAA 100YO KO/KO 1.13 1.04 GIPAT 100% KO 1.56 1.19
PPSA 100% KO/KO 1.04 1.02 G3PDH 100% KO/KO 1.13 1.04 G3PDH 100% KO/KO 1.57 1.19
PYKA 100% KO/KO 1.04 1.02 ZWF 100% 0 KO/KO 1.17 1.06 FBAB 100% KO/KO 1.58 1.19
FBAA 100% KO/KO 1.05 1.02 PFKA 100% (KO/KO 1.23 1.00 FBAA 100% KO/KO 1.58 1.19
FBAB 100% KO/KO 1.05 1.02 PFKB 100% KO/KO 1.24 1.01 ZWF 100% KO/KO 1.64 1.21
G3POH 100% KO/KO 1.05 1.02 RPIA 100% KO/KO 6.70 1.02 RPPK 100% KO/KO 1.75 1.24
RPIA 99.2% KO/KO 2.05 0.98 Ru5P 100% KO/KO 50.60 0.86 PFKA 100% K0/KO 1.77 1.16
PFKA 98.4% KO 1.07 0.96 Mur 100% KO 1.16 1.06 PFKB 100% KO/KO 1.78 1.17
TALA 98.4% KO/KO 1.07 0.96 FBP 100% KO/KO 1.16 1.06 Mur 100% KO/KO 1.80 1.26
MetSynth 98.4% KO/KO 1.07 0.96 MetSynth 100% KO/KG 1.16 1.06 SerSynth 100% KO/KO 1.92 0
PPSA 98.4% KO/KO 1.07 0.96 TALA 100% KO/KG 1.16 1.06 Synthl 100% KO/KO 1.85 1.28
PYKA 98.4% 1(0/1(0 1.07 0.96 PPSA 100% 1(0/KG 1.16 1.06 RPIA 100% (0/1(0 2.17 1.16
EDD 98.4% (0/1(0 1.07 0.96 EDD 100 1(0 K/KG 1.16 1.06 Ru5P 92.2% 0/1(0 3.64 1.13
FBAB 98.4% (0/1(0 1.07 0.96 PYKA 100 1(0/KG 1.16 1.06 PGM 100% 1(0 1.57 1.19
FB 984% _ 0 KO/KO_ 1.07 0.96 FBAA 100% KO/KO 1.16 1.06 G3PDH 100% KO/KO 1.58 1.19
G3P!H 98.4% 1(/._ 1.07 0.96 F _AB 100% 1(O/_0 1.16 1.06 FBAB 100% 1(/1O_ 1.58 1.19
TKb 93.0% 2.00/1.90 1.09 1.00 G3PDH 100% KO/KG 1.16 1.06 FBAA 100% KO/KO 1.58 1.19
ZWF 100% KO/KO 1.13 0.98 ZWF 100% KO/KO 1.20 1.08 ZWF 100% KO/KO 1.64 1.21
Table 2. The list of best strategies for improving aromatic amino acid productions
Strategies Support E/Eo Score Serine Strategies Support E/EO Score Serine Strategies Support E/E0 Score Serine
RPPK 100% KO/KO 1.76 1.24 PGK 98.4% 10/0.1 12.32 0.96 G3PDH 100% KO/KO 68.82 6.94
PFKA 100% KO/KO 1.78 1.17 PGM 100% 10/KO 13.63 1.13 ZWF 100% KO/KO 69.20 6.94
PFKB 100% KO/KO 1.79 1.17 RuSP 100% 10/KO 16.62 0.92 RPIB 100% KO/10 69.93 6.78
Mur 100% KOIKO 1.80 1.26 GPMB 99.2% 10/10 25.76 2.28 TKa 100% KO/0.55 70.18 6.68
Synthl 100% KO/KO 1.86 1.28 GPMA 98.4% 10/0.1 26.37 2.33 TKb 100% KO/2 70.68 6.65
SerSynth 100% KO/KO 1.92 0 PYKF 100% 10/KO 28.41 1.66 Mur 100% KO/KO 73.19 7.05
RPIA 100% KO/KO 2.18 1.16 GAPA 99.2% 0.1 13.08 0.92 PFKB 100% KO/KO 73.22 6.37
Ru5P 92.2% KO/KO 3.65 1.13 PYKA 100% 0.1/KO 13.09 0.92 RPIA 100% KO/KO 77.60 6.54
PYKF 100% KO 4.03 1.93. TIS 99.2% 0.1/1.61 13.09 0.92 RPPK 100% KO/KO 78.02 7.18
G3PDH 100% KO/KO 4.08 1.94 TALB 99.2% 0.1/1.90 13.09 0.92 GIPAT 100% KO/KO 94.90 7.53
PFKA 100% KO/KO 4.14 1.84 G3PDH 100% 0.1/KO 13.44 0.92 PGM 100% KO/KO 95.12 7.53
ZWF 100% KO/KO 4.28 1.98 RPIB 99.2% 0.1/1.27 13.11 0.92 GPMB 100% KO/10 109.47 8.16
PFKB 100% KO/KO 4.29 1.80 FBAB 99.2% 0.1/2.34 13.11 0.92 GPMA 100% KO/0.1 110.09 8.18
Mur 100% KO/KO 4.79 2.09 ENO 99.2% 0.1/0.66 13.12 0.92 Synthi 100% KO/KO 120.10 8.23
RPPK 100% KO/KO 4.84 2.09 RPPK 99.2% 0.1/0.97 13.14 0.92 SerSyrnth 100% KO/KO 138.41 0
RPIA 100% KO/KO 5.50 1.84 GIPAT 99.2% 0.1/0.98 13.17 0.92 GAPA 100% KO/0.1 202.32 3.68
PGM 100% 0.1/KO 5.70 2.23 ZWF 100% 0.1/KG 13.69 0.93 DAHPS 100% KO/10 220.30 4.66
Synthl 100% KO/KO 6.17 2.38 TKa 99.2% 0.1/0.49 14.17 0.89 PYKF 100% KO/KO 244.80 9.80
SerSynth 100% KO/KO 6.80 0 TKb 93.8% 0.1/2.40 14.23 0.88
GIPAT 100% KO/KO 6.94 2.47 Ru5P 100% 0.1/KO 14.62 0.92
PGM 100% KO/KO 6.96 2.47 Synth1 100% 0.1/KG 14.72 0.96
Ru5P 100% KO/KO 7.14 1.82 Mur 100% 0.1/K 14.95 0.96
GPMB 100% 10/KG 9.94 3.62 SerSynth 100% 0.1/KO 15.07 0
GPMA 100% 0.1/KO 10.09 3.66 PGK 99.2% 0.1/0.1 17.58 0.89
DAHPS 98.4% 10 9.02 0.97 PGM 100% 0.1/KO 19.81 1.06
TS 98.4% 10/4.44 9.03 0.97 GPMA 99.2% 0.1/0.1 31.95 2.13
G3PDH 100% 10/KO 9.06 0.97 PYKF 100% 0.1/KG 35.52 1.44
TALB 98.4% 10/5.72 9.11 0.97 DAHPS 99.2% 0.1/10 74.74 0.75 1
ZWF 100% 10/KO 9.36 0.99 PPC 100% KO 66.63 6.88
ENO 98.4% 10/0.1 9.50 1.01 TALA 100% KO/KO 66.64 6.88
RPIB 98.4% 10/8.64 9.63 0.96 PPSA 100% KO/KO 66.64 6.88
RPPK 98.4% 10/0.17 9.84 1.00 PTS 100% KO/2 66.65 6.88
TKa 98.4% 10/0.39 10.11 0.94 PYKA 100% KO/KO 66.66 6.88 1
TKb 98.4% 10/2.58 10.25 0.94 EDD 100% KO/KO 66.66 6.88
Synth1 100% 10/KO 10.28 1.03 TALB 100% KO/2 66.73 6.87
Mur 100% 10/KO 10.34 1.02 TIS 100% KO/2 66.74 6.88
SerSynth 100% 10/KO 10.55 0 PFKA 100% KO/KO 67.06 6.80
RPIA 100% 10/KO 10.72 0.95 FBAA 100% KG/KG 67,54 6.90
G1PAT 98.4% 10/0.52 10.98 1.04 FBAB 100% K0/8 68.42 6.92
Table 2 (continued). The list of best strategies for improving aromatic amino acid productions
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Chapter 3
Systematic bottleneck identification and
release for Saccharomyces cerevisiae ethanol
production
Abstract
Increased concern for the cost and supply of oil and its negative impact on the environment
has led to recent interest in renewable fuel alternatives. Most biofuels share similar precursors in
the central carbon metabolic network, and ethanol is the most common renewable fuel today.
The study of ethanol production from the central carbon metabolic network is becoming a classic
case for the development of techniques to understand and manipulate Saccharomyces cerevisiae
for optimized biofuel production. Here we present and apply a mass-action model ensemble for
the Saccharomyces cerevisiae central carbon metabolic network that incorporates the ethanol
synthesis pathway as well as the dynamics of NAD and NADH interconversion. This model
ensemble, which samples over parameter uncertainties, was used to design and then to analyze
strategies that improve ethanol production. We further explored approaches for the identification
of pathway bottlenecks. Four computational assays were studied, including metabolite
accumulation, conditional Vmax, increased input, and decreased enzyme, which were applied to
the ethanol model ensemble to study bottleneck identification in this network. The TDH reaction
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was detected as a major bottleneck restricting carbon flow towards the ethanol pathway and
affecting NADH availability. A computational process of greedy sequential single enzyme over-
and under-expression optimization was then conducted and several strategies were identified that
together improve the ethanol yield of a majority of models beyond 95% of the theoretical yield.
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3.1 Introduction
Metabolic engineering has been widely used as an efficient tool to optimize the production of
industrial and commercial chemicals. It usually involves directed improvement of cellular
properties, using recombinant DNA technologies, through modification of specific biochemical
reactions or introduction of new reactions. Many successful applications have been reported to
elevate chemical production by re-engineering the genomes of microorganisms, in which popular
synthetic chemicals include amino acids, polymers, lipids, and biofuels (Alper & Stephanopoulos,
2009; Atsumi & Liao, 2008; Bailey, 1991; Barkovich & Liao, 2001; Bongaerts et al., 2001;
Cameron & Tong, 1993; Cameron & Chaplen, 1997; Keasling, 1999; Li & Vederas, 2009;
Stephanopoulos & Sinskey, 1993; Tyo et al., 2007). Because many of the desired metabolic
products are terminal or intermediate compounds of central carbon metabolism, composed of
glycolysis and the pentose phosphate pathway, it has become one of the most intensively studied
biochemical systems. Recent concerns about greenhouse gas emissions, as well as the supply and
cost of oil, have led to interest in alternative liquid transportation fuels, an often-touted version
of which is the cellular conversion of biomass into ethanol and other alternative fuels produced
from similar metabolic intermediates that are found in the glycolysis pathway (Alper &
Stephanopoulos, 2009). Regardless of which molecule or mix of molecules becomes the
dominant biomass-based fuel of the future, microbial conversion is at present the main avenue
for alternative fuel production. Ethanol production through the central carbon metabolic network
has become a useful case study to develop computational techniques to help improve the
fermentation production of renewable biofuels (Bro et al., 2006; Lee et al., 2008; Matsushika et
al., 2009).
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The most commonly used microbe for ethanol production has been yeast; Saccharomyces
cerevisiae which can produce ethanol to concentrations as high as 18% of the fermentation broth,
is the preferred species for most ethanol fermentation (Lin & Tanaka, 2006). This yeast can grow
both on simple sugars, like glucose, and on the disaccharide sucrose. As with many
microorganisms, Saccharomyces cerevisiae metabolizes glucose by the Embden-Meyerhof (EM)
pathway (Lin & Tanaka, 2006). Under aerobic conditions, the pyruvate formed in the final step
of glycolysis is oxidized to acetyl-CoA, which enters the citric acid cycle and is oxidized to CO 2
and H20. Under anaerobic conditions, there is no 02 to accept the electrons of NADH and thus
to reoxidize it to NAD, which threats the function of the glycolysis pathway. Saccharomyces
cerevisiae evolved to continually regenerate NAD during anaerobic glycolysis by transferring
electrons from NADH to ethanol, a reduced end product (Nelson & Cox, 2008; Pronk et al.,
1996). Pyruvate is converted to ethanol and CO 2 in a two-step process: pyruvate is decarboylated
in an irreversible reaction catalyzed by pyruvate decarboxylase; the acetaldehyde generated is
then reduced to ethanol through the action of alcohol dehydrogenase with the reducing power
furnished by NADH. These two steps can be combined into an overall reaction:
Pyruvate + NADH -I Ethanol + CO 2 + NAD (1)
As can be seen in this pathway, the NAD/NADH balance plays a crucial role in regulating the
flux distribution in the network. NADH and the related coenzyme NADPH serve different
functions in Saccharomyces cerevisiae metabolism. NADPH is mostly used as a reductant in
biosynthetic reactions; whereas the NADH/NAD ratio mainly determines the intracellular redox
potential (Bakker et al., 2001; Vemuri et al., 2007). The total amount of NADH and NAD can be
considered as a conserved quantity (Bakker et al., 2001). Reduction of NAD must be matched by
continuous reoxidation of NADH. There are several major 'sources and sinks' of NADH in the
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central carbon metabolic network (Bakker et al., 2001; Hou & Vemuri, 2010; Vemuri et al., 2007)
as shown in Figure 1. NADH is mainly produced by the gapA reaction in the glycolysis pathway,
where it participates in the conversion of glyceraldehyde 3-phosphate to 1,3-bisphosphoglycerate.
Under aerobic conditions, additional NADH is produced through the citric acid cycle. The major
pathway to reoxidize NADH to NAD when oxygen is available is the respiration pathway in
mitochondria. In anaerobic conditions oxygen is not present to accept electrons from NADH.
Instead, ethanol is synthesized from pyruvate to reoxidize the NADH. In addition, the glycerol
synthesis pathway, which uses dihydroxyacetone phosphate in the glycolysis pathway as a
reactant, is also used to reoxidize the NADH that cannot be fully consumed by ethanol synthesis
in order to maintain the NAD/NADH balance. The dynamics of the NAD/NADH
interconversion is controlled by this complex network under aerobic and anaerobic conditions. It
determines the relative fluxes among different pathways, and thus is crucial to understand for the
purpose of optimizing ethanol production in Saccharomyces cerevisiae.
Due to the importance of ethanol in industrial use, much effort has gone into maximizing its
production. Improvements include pretreatment of feedstocks and introducing enzymes to digest
xylose (Hahn-Hagerdal et al., 2006; Lee et al., 2008; Lynd, 1996; Matsushika et al., 2009;
Nevoigt, 2008; Sinchez & Cardona, 2008). Less attention has been focused on regulation of the
overall central carbon metabolic network and on understanding bottlenecks in this network.
Because of the complexity of the NAD/NADH dynamics in this network, computational and
mathematical models may be especially useful in understanding and optimizing ethanol
production.
Recent research has led to computational models in order to efficiently analyze and optimize
metabolic networks. Two of the major model types that have been developed and applied are
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flux balance analysis (FBA) and ordinary differential equation (ODE) models (Burgard et al.,
2003; Chassagnole et al., 2002; Edwards & Palsson, 2000; Pramanik & Keasling, 1998; Schmid
et al., 2004; Usuda et al., 2010; Vital-Lopez et al., 2006). FBA models require relatively modest
information regarding biological mechanism, including a list of chemical reactions with their
stoichiometry, flux constraints, and specification of feeds and metabolic demands (Kauffman et
al., 2003; Stephanopoulos et al., 1998; Varma & Palsson, 1994), most of which can be readily
acquired from existing literature and databases. Therefore, FBA models have the advantage of
feasibility and simplicity when modeling large-scale (e.g., whole genome) networks. In contrast
to the steady-state nature of FBA models, ODE models, including aggregated rate law (ARL)
and mass-action rate law (MRL) forms, incorporate network dynamics and attempt to represent
detailed enzyme behavior (Chassagnole et al., 2002; Lee et al., 2006; Liao et al., 1996; Tzafriri,
2003). If unconstrained, the space of steady states from both FBA and ODE models are the same,
but ODE models can readily map parameter constraints into the kinetically feasible regions of
the solution space, whereas this information is not easily transferable to FBA models (Machado
et al., 2012).
A mass-action rate law model for the E. coli central carbon metabolic network has been
reported in Chapter 2, which includes glycolysis and the pentose phosphate pathway. As the
ethanol synthesis pathway is an extension at the end of the glycolysis pathway, the model in
Chapter 2 serves as a convenient initial model for this study. To convert the E. coli model into a
Saccharomyces cerevisiae model, the topology of the model in Chapter 2 was updated based on
the KEGG database (Kanehisa & Goto, 2000). To keep the conversion simple and focused on the
important features of NAD and NADH dynamics, we kept the same number of isomers for the S.
cerevisiae model as for the E. coli model. For reactions that have isomers in S. cerevisae but not
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in E. coli, the general name of the S. cerevisae gene was used (e.g., PGM was used for S.
cerevisae instead of PGMI, PGM2, and PGM3). For reactions have isomers in E. coli but not S.
cerevisae, the weaker isomer reaction in E. coli was removed. The gene names were updated to S.
cerevisae names based on the KGEE database. The parameters were re-fitted against the steady-
state flux data of the key branching reactions in the glycolysis pathway, pentose phosphate
pathway, and TCA cycle measured for S. cerevisiae (Jouhten et al., 2008). More importantly,
given NADH as a reactant for the ethanol synthesis reaction, the NAD and NADH
concentrations were added as explicit state variables into the model in order to analyze their
impact on ethanol production. The steady-state concentrations for NAD and NADH under
aerobic conditions (1.47mM and 0.1 mM, respectively) were borrowed from their E. coli
measured data (Chassagnole et al., 2002) as no S. cerevisiae measurements reported; however,
the total amount of NAD and NADH (around ImM) reported for S. cerevisiae (Bakker et al.,
2001) is similar to the total amount used in our models. The ethanol synthesis pathway was also
added to the model, with pyruvate and NADH as the two reactants. In the refitting, a collection
of models, instead of a single model, was produced, all of which have similarly good fits to the
flux and concentration data mentioned above. This ensemble provides an estimate of uncertainty
in the parameters fit and in the predictions made.
Although much effort in the field of metabolic engineering has gone into identifying efficient
strategies to improve the production rate of desired chemicals, there is less research on how to
directly and systematically discover the bottlenecks in the system -- that is, to identify the slow
steps that would presumably be high-priority targets for rational genetic engineering. In order to
increase productivity and metabolite yield, researchers have focused on enzyme amplification or
other modifications of the pathway that produce increased yield (Stephanopoulos & Vallino,
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1991). Retrospectively, an enzyme reaction can then be called a bottleneck because its
overexpression has improved productivity (Dai et al., 2002; Ltitke-Eversloh & Stephanopoulos,
2008). Here we take a complementary approach of independently studying bottlenecks through a
variety of approaches and then examining the effect of releasing them through overexpression in
simulation.
Alternative approaches such as metabolic control analysis (MCA) (Heinrich & Rapoport,
1974; Kacser & Bums, 1973) have been developed; however, their value in directing metabolic
engineering efforts remains uncertain. MCA, for example, is only valid in the local neighborhood
of the operating point (e.g., steady state) evaluated (Stephanopoulos & Vallino, 1991). This can
limit its applicability. Dynamic sensitivity analysis was developed and applied to primary
metabolism, in which the relative change of target metabolite concentration caused by an
infinitesimal percentage change in enzyme activity is calculated for each enzyme and used to
predict bottlenecks (Shiraishi & Suzuki, 2009). One drawback of this method is that the
sensitivity is calculated through differential equations which evaluate the production
improvement effect when changing the enzyme activity for only an infinitesimal percentage,
which is not realistic in experiments and may not hold valid when changing the enzyme activity
for a finite level. While useful, this approach provides only one perspective on bottlenecks
(discussed below). Network rigidity and principal nodes theory, developed by Stephanopoulos
and Vallino (1991), can identify nodes in the network that have inherent resistance to flux
partitioning alterations. The relative flux going down a certain branch of those nodes may not be
changed by simply modifying the corresponding enzyme activities. Those nodes, therefore,
should be given more attention when designing engineering strategies to improve the production
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rate of metabolic products on the branching pathways and can be considered as a different type
of "bottlenecks" for this concern.
Here we present a framework to systematically identify bottlenecks in the system and study
their relevance for production of a desired output. Four computational tests involved in the
framework are illustrated in Figure 2. They are metabolite accumulation, conditional Vma,
increased glucose input, and decreased E0. Based on the model ensemble we built for
Saccharomyces cerevisiae, we were able to identify bottlenecks in the central carbon metabolic
network through their framework. Analysis of these bottlenecks has led to insights about the
production of ethanol by the network.
Here we describe the four tests used for bottleneck identification. Detecting metabolite
accumulation is a method that is often used by experimentalists to identify network bottlenecks.
Significant (and possibly increasing) accumulation of certain metabolites when others appear to
have reached a constant low level can indicate a flux imbalance adjacent to the accumulated
metabolite. That is, a slower consuming flux cannot keep up with a faster generating flux. The
slow consuming flux usually indicates pathway bottleneck. Several studies have achieved
improved production rates of target chemicals by releasing these bottlenecks (Martin et al., 2003;
Simonsen et al., 2012). Adopting the same logic, our metabolite accumulation test works by
computationally detecting metabolite accumulations in the network. We simulate the model
ensemble of the central carbon metabolic network until most of the metabolites in the system
have reached a constant level, consistent with the experimental fermentation time (Lin & Tanaka,
2006). Upon further simulation, some metabolites retain their constant concentrations, but others
increase significantly. The first time point defines a pseudo-steady state of the system and serves
as a reference state, and the later one is used to detect metabolite accumulation. The flux
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immediately downstream of these accumulated metabolites is bottleneck candidate to be
examined further with the other three tests. Interestingly, rather than identifying a single rate-
determining step, here this approach found multiple slow steps simultaneously.
Based on our calculations (see Results and Discussion), many of the slow fluxes identified
through metabolite accumulation operate below their maximum Vmax. These fluxes don't use the
extra capacity because they tend to be reactions with multiple (two) substrates with one of the
substrates (usually the non-accumulated of two) limiting. Increasing the concentration of the
limiting substrate (a metabolite) generally could involve a shift to a new steady state which leads
to a faster flux. We thus introduce the concept of a conditional Vm.ax of an enzyme with respect to
a substrate to describe a system property of the enzyme where the actual flux capacity is limited
by the given steady state (or pseudo-steady state) of the substrates (occasionally also products)
and is smaller than the overall V.ax. The overall Vmax is a local property of the enzymes
determined by the enzyme kinetic parameters (e.g., kcat) and the enzyme availability (e.g., total
enzyme concentration, Eo). It does not depend on the system or network the enzyme locates and
describes a fixed upper limit for enzyme flux capacity. In contrast, the conditional Vmax describes
a realizable enzyme flux capacity at a given (pseudo-) steady state. For example, if one substrate
(usually a co-factor) of a two-substrate enzymatic reaction remains at a significant low steady-
state concentration determined by the system, no matter how much the other substrate
concentration is increased, the enzyme cannot run at its Vmax. We call the enzyme is running at
its conditional Vniax respecting to the first substrate and the first substrate is the limiting factor.
Under situation like this, the overall Vmax is useless, but it is the system property, the conditional
Vmax which depends on the current network concentration states, that provides valuable
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information of the available capacity of an enzymatic reaction. For single substrate reactions, the
conditional Vmiax, when holding product level at zero, is the same as the overall Vmax.
The metabolite accumulation test and the conditional Vmax test are methods to identify
bottleneck candidates. They make no reference to the desired output compound however and so
can suggest bottlenecks not relevant to production. The glucose input test and decreased Eo test
are additional tests that measure the relevance of candidates to production of the desired output.
As the ethanol production pathway is located near the end of glycolysis, whether the carbon
resources provided by glucose can reach this pathway efficiently is important for optimizing
ethanol yield. The glucose input test increases the glucose input flux by 2 to 1000 fold. If there is
no bottleneck for carbon flux in the network, all fluxes should be elevated with increased glucose
input. On the other hand, the bottleneck flux (and those downstream) will not increase when
increasing glucose input, as maximum capacity has been reached. By observing flux changes for
each enzyme in central carbon metabolism for increased glucose input, we were able to identify
the enzymes that constrain the carbon flux.
The fourth test, decreased E0, is based on the assertion that if an enzyme reaction is a
bottleneck, it is already running at capacity; reducing the capacity by decreasing Eo should
further reduce downstream fluxes to the output, but not for non-bottlenecks. It is tempting to
propose an increased E0 test, as this corresponds to experimentally implemented enzyme
overexpression. Similar conclusions cannot as clearly be drawn for an increased E0 test, however,
because the flux might still be limited by something else (for instance, a second bottleneck);
release of either alone would not increase production, but both together would.
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Based on this four-test framework, we were able to identify bottleneck candidates in the
central carbon metabolic network and validate their relevance for ethanol production. The TDH
reaction, which is several steps upstream of the ethanol synthesis reaction, is identified as an
important bottleneck that regulates the carbon flow towards ethanol production. The NAD to
NADH ratio emerges as a crucial regulator for the TDH reaction and ethanol production. It
controls the balance and relative abundance of the carbon precursor, pyruvate, and the NADH for
ethanol synthesis. As the NAD and NADH molecules are involved in several enzyme reactions,
the fluxes of which are interdependent due to the network topology, it is not obvious how to
manipulate the enzymes in the network for optimum balance between NAD and NADH in order
to maximize ethanol yield. Here we use a single-enzyme, greedy sequential optimization method
to identify efficient strategies to enhance ethanol production. In each round, single-enzyme over-
or under-expression optimization was conducted, using similar procedures to those reported in
Chapter 2, for each enzyme in the network and for each model in the ensemble. Compared to the
exhaustive multiple-enzyme optimization reported in Chapter 2, the single-enzyme greedy
optimization is computationally more efficient (scales as the number of enzymes in the network
as opposed to combinatorially). Two rounds of sequential optimization are computed to lead to
raising ethanol yields from 75-85% to over 95% of the theoretical maximum for most of the
models in the ensemble. Further studies show that the strategies identified through this method
helped release the bottlenecks identified by the four-test framework. The model ensemble
technique and the bottleneck identification and release methods reported here can be readily
applied to extended pathways of central carbon metabolism and other networks to help improve
the production of chemicals of academic or commercial interest.
94
3.2 Method
3.2.1 Modeling ethanol production in yeast central carbon metabolic network
A mass-action rate law model for E. coli central carbon metabolic network, which includes
glycolysis pathway, pentose phosphate pathway, and Entner-Doudoroff pathway, has been
reported in Chapter 2. As the central carbon metabolic network is highly conservative among
many microorganisms (Nelson & Cox, 2008), this model provides a good reference for
generating a comprehensive mass-action rate law model for Saccharomyces cerevisiae. In order
to update the model topologies from E. coli network to Saccharomyces cerevisiae network, the
KEGG database (Kanehisa & Goto, 2000) was used to select model additions and deletions. The
glucose uptake in Saccharomyces cerevisiae involves glucose membrane transporters (H XT) and
hexose phosphorylation enzymes (HXK1, HXK2, and GLK) (Barnett, 2008; Boles & Hollenberg,
1997; Fernandez, Herrero, 1985; Gancedo, 2008; Leandro, Fonseca, & Gongalves, 2009; Ozcan
& Johnston, 1999; Rintala, Wiebe, Tamminen, Ruohonen, & Penttila, 2008; Rolland,
Winderickx, & Thevelein, 2002), the mechanisms of which are different from the glucose uptake
of E. coli. The pts reaction (E. coli glucose uptake and phosphorylation reaction) in the E. coli
model was replaced by an artificial GT reaction for glucose transporter and HXK reaction for
glucose phosphorylation to simulate the glucose uptake for Saccharomyces cerevisiae. The
chemostat experimental setting in the E. coli model was replaced by a batch experimental setting,
by removing the constant in-flux and out-flux of glucose for the system and replacing with a
fixed initial extracellular glucose supply of 36 g/L. The elementary parameters for reactions GT
and HXK were estimated based on the literature Km and kcat value (Fernandez, Herrero, 1985;
Gao & Leary, 2003), and the enzyme concentrations of them were adjusted so that the system
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remains a similar glucose uptake rate as the model in Chapter 2. The Entner-Doudoroff pathway
(edd and eda) was removed from the model, as it does not exist in Saccharomyces cerevisiae
(Blank, Lehmbeck, & Sauer, 2005). The anaplerotic reaction pepc in the E. coli model was
replaced by PYRD reaction for the Saccharomyces cerevisiae model, as the pyruvate carboxylase,
instead of the phosphoenolpyruvate carboxylase, is the major enzyme to replenish the citric acid
cycle for oxaloacetate which is consumed during biosynthsis of amino acids. The PYRD reaction
was implemented to be sensitive to the concentration of acetyl-CoA to simulate the natural
behavior of this enzyme (Pronk et al., 1996). The ethanol production pathway was added as a
new branch taking away pyruvate and converting it into ethanol (Pronk et al., 1996). The detailed
reaction mechanisms can be found in the Appendix B.
The critical modifications of the Cui et al. model were the introduction of NAD/NADH and
NADP/NADPH balance into the model as well as the capability to model the transition from
aerobic to anaerobic conditions. The mechanisms of the major reactions responsible for the
NAD/NADH and NADP/NADPH balance were updated to include NAD, NADH, NADP, and
NADPH as reactants or products. In particular, the TDH enzyme reaction was updated from a
uni-uni reaction to a bi-bi reaction to include NAD as reactant and NADH as product. A
simplified three-reaction citric acid cycle (TCA cycle), which only takes into account of the three
steps involving NADH generation, was also added into the model to simulate the NADH
generation from NAD. The glycerol synthesis reaction and the ethanol synthesis reaction were
updated to include NADH as reactant and NAD as product, as the alcohol generation steps
consume NADH for redox balance. A simplified oxidative phosphorylation reaction was added
to simulate the conversion of NADH to NAD by oxygen under aerobic condition. Oxygen, which
was added as a tractable variable in the model, starts at a constant level and linearly decreases
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while consumed by the oxidative phosphorylation reaction. Oxygen concentration hitting a zero
marks the system converts from aerobic condition to anaerobic condition. The ZWF] and GND
reactions were updated to include NADP as reactant and NADPH as product; a first-order
reaction was added to simulate the consumption of NADPH to NADP by biosynthesis reactions
in yeast. The detailed reaction mechanisms and reference used for the reactions mentioned above
are listed in Table 1. After the modifications, the new yeast model consists of 46 enzyme
reactions, 235 species, and 423 free kinetic parameters. Figure 3 depicts the overall topology of
the model.
The carbon flux distribution measurement data of Saccharomyces cerevisiae CEN.PK1 13-1A
in different oxygenation conditions reported by Jouhten et al. (Jouhten et al., 2008) were used to
train the wild-type model behavior. In particular, the fluxes of the crucial branching reactions,
ZWF1, GND, glycerol synthesis, TDH, ethanol synthesis, FBA1, PYK, PYRD, PG11, PDB], and
the first TCA reaction, in both aerobic and anaerobic conditions were included in the objective
function for the parameter fitting. In addition, the concentrations of NAD and NADH under
aerobic condition were also included in the objective function of the fitting, so that the system
has a reasonable NAD/NADH balance at the initial stage of the experiment. The overall
objective function for the fitting is given as below:
2 2
G = rPredaerobic - rdata,aerobic + rpredanaerobic - rdataanaerobic
rdataaerobic 
6 data,aerobic rdata,anaerobic 
6data,anaerobic
/ 2
Xpred,aerobic - Xdata,aerobic)
xdataUaerobic Cdata,aerobic
The first and second sums are for the reaction rate fitting for the 11 branching reaction fluxes
under aerobic and anaerobic conditions. The third sum is for the NAD and NADH concentration
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fitting under aerobic conditions. The NAD and NADH concentrations under aerobic conditions
were taken from Chassagnole et al. (2002). Six parameter sets from the frontier model sets in the
Chapter 2 model that represent the different pentose phosphate pathway behaviors were selected
as the initial parameters for the fitting. For each parameter set, four additional initial parameter
sets were generated by adding 10% random noise to each parameters. An Eo of 0.0176mM was
used for all enzymes except for the glucose transporters (Fraenkel, 2003). To take into account of
the uncertainties of average enzyme concentrations in yeast, each parameter set was also paired
with one of the five E0, 0.001mM, 0.005mM, 0.01mM, 0.025mM, 0.05mM, for the parameter
fitting. In total, 180 initial parameter sets were used for the optimization which was done using
the fmincon function in MATLAB (version 2008a; The MathWorks, Inc.; Natick, MA). The
boundaries of parameters were partially estimated based on Km and kcat reported in BRENDA
database (Scheer et al., 2010). 52 parameter sets were collected with good fits. These parameter
sets formed a model ensemble with 52 sub-models which share the same topology but have
different parameter values.
3.2.2 Calculation of metabolite accumulation
Each model was simulated to ti = 105s (27.8 hour) and to t2 = 1.5 x 105 s (41.7 hour). The t
time point was selected as a long enough time to allow the system reaches a pseudo-steady state.
It is consistent with the range of experimentally used measurement time for batch reactors
(Cheng & Hasan, 2009; Dombek & Ingram, 1987; aylak & Sukan, 1998). The concentrations
of all metabolites were collected at both time points. A comparison between the concentrations at
the first time point and those at the second time point showed that most of the intermediate
metabolites but eight stay at the same level. We then defined the first time point as a "pseudo-
steady state", which refers to a state that all but some "special behaving" metabolites have
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reached stable concentrations. The "special behaving" metabolites did not reach stable
concentrations when allowed to simulate up to 2x 105s (55.6 hour). The ratios of the metabolite
concentrations at t2 over ti were reported as indicators of abnormal metabolite accumulations in
the system.
3.2.3 Calculation of conditional Vmax
To calculate conditional Vm.ax, each model in the ensemble was first simulated to acquire
pseudo-steady state concentrations for all species at the given measurement time point t = 27.8
hour. For multiple reactants enzyme reaction, the conditional Vmax for a particular reactant was
calculated as the maximum flux this reaction can achieve when changing the concentration of
this reactant from zero to infinity (1010 mM was used for calculation) while fixing the
concentrations of all other reactants and products at the pseudo-steady state values simulated as
described above. The fluxes for each concentration state were calculated based on the steady-
state rate law derived using the King-Altman method from the elementary reactions (Cleland,
1963; Cornish-Bowden, 1977; King & Altman, 1956; Kuzmic, 2008). For single reactant enzyme
reactions, the conditional Vmax was calculated with fixed product pseudo-steady state
concentrations while changing the concentration for reactant from zero to infinity (1010 mM was
used for calculation). The conditional Vmax was calculated for every reactant of each enzyme
reaction. The actual enzyme flux for each reaction was also calculated based on the pseudo-
steady state concentrations of all species. The ratio between the actual flux and the conditional
Vmax is an indicator of the usage of flux capacity and is reported in Results and Discussion
session.
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3.2.4 Measurement of the effect of increasing glucose input
The Eo of GT and HXK enzymes were increased for 2, 5, 10, 25, 50, 100, and 1000-fold to test
increasing the glucose input for the corresponding fold for each model. The extracellular glucose
was kept excessive for all the tests. Under each glucose input level, the models were simulated to
the pseudo-steady state (t = ti) and the enzyme fluxes were calculated as the time derivative of
the product concentration of each reaction at the pseudo-steady state. The pseudo-steady state
flux changes for each enzyme of each model when increasing the glucose input level were
reported as a measurement of effect of increasing glucose input.
3.2.5 Measurement of the effect of decreasing enzyme Eo
The enzymes detected as bottleneck candidates based on the metabolite accumulation test and
the conditional Vmax test were measured for their effect on ethanol production rate when
decreasing their corresponding Eo. The Eo of glycerol synthesis enzyme, TDH, TALl, NQM1,
and the first enzyme in the TCA cycle were decreased to 80%, 50%, 10%, and 1%, respectively.
The corresponding pseudo-steady state flux changes for ethanol production were reported as
indicators of the relevance of the particular bottleneck candidate to the production rate of interest.
3.2.6 Sequential bottleneck release
A sequential single enzyme optimization framework was applied to the model ensemble to
identify strategies leading to enhanced ethanol production. The objective function was the
ethanol production rate from the reaction catalyzed by the enzyme Eole from the substrates
pyruvate, evaluated at the pseudo-steady state. A single enzyme over- and under-expression
(termed "expression change" here) spanning a range from 50 times to 1/50 the unperturbed
concentration was tested for each of the enzymes in the system for the model ensemble. The
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enzyme expression change strategy that results in the most increase of the ethanol yield
compared to that of the wild-type model was selected as the best strategy for that model at round
1. The best strategies for each model in the ensemble were applied to the wild-type models,
which generates the new base models. A second round optimization of single enzyme expression
change was then conducted on the base models to identify strategies that lead to the best increase
of ethanol yield. This process can be repeated several times until a preferred yield is achieved or
no further yield improvement can be acquired. A corresponding sequence of single enzyme over-
and under-expression for each model in the ensemble can be generated as the roadmap to
enhance ethanol production. The optimization was done using the f mincon function in MATLAB
(version 2008a; The MathWorks, Inc.; Natick, MA).
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3.3 Results and Discussion
The central carbon metabolism model for E. coli built in Chapter 2 was converted to a model
ensemble for Saccharomyces cerevisiae with updated network topology. The steady-state
concentrations of NAD and NADH under aerobic condition were borrowed from those in E. coli
(Chassagnole et al., 2002) given the total amount of them is similar in E. coli (1.57mM) and in S.
cerevisiae (around 1mM) described in Introduction.The model ensemble was reparameterized
using steady-state data of major carbon fluxes in S. cerevisiae through the glycolysis pathway,
pentose phosphate pathway, and the TCA cycle under both aerobic and anaerobic conditions
(Jouhten et al., 2008). The resulting models fit the training data very well, with 82.1% of the
calculated fluxes within 10% of the measured values and a maximum deviation of 24.6%.
3.3.1 Ethanol production bottleneck detection via the four-test framework
Metabolite accumulation test and conditional V,,,, test identify bottleneck candidates for further
investigation
Each of the 52 models in the ensemble was examined for metabolite accumulation. Each
model was simulated and examined at ti = 27.8 h and t2 = 41.7 h as described in Methods session.
Nearly all metabolites had reach low concentrations that remained constant over time at ti,
comparison between t2 and t, provided a convenient mechanism to identify those that
accumulated. The log ratios of the metabolite concentrations collected at t2 to that at tIare shown
as a heat map in Figure 4A, where the x-axis corresponds to different metabolites in the model
and y-axis corresponds to different models in the ensemble. The rows are ordered by the model's
ethanol yield, with the highest yield model at the top. The panel on the right of the heat map
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shows the corresponding yield for each model. Red indicates a significant concentration increase;
blue represents a significant decrease. Intermediate colors indicate intermediate changes.
The majority of the 26 metabolites consistently show consistent green color across all or
nearly all models, which indicates small or no concentration change. The consistency across
models indicates insensitivity to parameter uncertainties between models. One can consider the
systemas having reached a pseudo-steady state by ti, as most of the metabolites have reached a
stable level. Interestingly, several metabolites increase concentration (yellow to red) - namely,
F1,6P, G3P, E4P, DHAP, and acetyl-CoA. Moreover, those increases are consistent across most
of the models, which again indicates a relative insensitivity to parameters. Figure 4B shows a
box plot that summarizing the distributions across models from the heat map for each metabolite.
The five accumulated metabolites have the largest variation across models partially because the
models vary in the level of accumulation predicted but also because some models predict no
accumulation.
The carbon flow through glycolysis starts at glucose and progresses towards pyruvate. The
metabolites F1,6P, DHAP, and G3P are located immediately before the enzyme reaction
catalyzed by the product of the TDH gene. A concentration accumulation at this location
indicates an imbalance of fluxes going into and out of these metabolites. In particular, it suggests
the TDH and glycerol synthesis fluxes are slower than the PFK and FBA I fluxes and that the
FBA 1 fluxes are slower than the PFK ones (also confirmed by other results, see below), which
identifies TDH and the glycerol synthesis reactions as potential bottlenecks. Similarly, the
accumulation of acetyl-CoA suggests the first reaction in the TCA cycle, TCA1, could be a
potential bottleneck of the system. It is more complicated for the accumulation of E4P, as
reported in Chapter 2 that the flux in pentose phosphate pathway can flow in either the clockwise
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or counter-clockwise direction. Both the TAL and TKL reactions could be potential bottlenecks
depending on the flux direction.
To complement the metabolite accumulation simulations, the conditional Vmax for each
enzyme reaction was calculated for each model in the ensemble. As conditional Vmax measures
the maximum flux under current condition, the log ratios of actual fluxes to their condition Vm.ax
are given in Figure 5. Red indicates fluxes that are similar to the conditional Vmax and thus close
to capacity; the deepest blue indicates fluxes than 1% of their conditional Vmax and thus far
below capacity. Of the five accumulated metabolites identified above (E4P, acetyl-CoA, G3P,
DHAP, and F 1,6P), there is a corresponding enzyme running at its conditional Vmax just
downstream (TAL, TCA, TDH, and GLCE, respectively). This is as expected as described in
Figure 2B: bottleneck candidates predicted by the metabolite accumulation test should also be
selected by the conditional Vmax test, because metabolite accumulation indicates the consuming
flux cannot keep with the generating flux, which suggests the consuming flux is already running
at capacity. Interestingly, several new enzyme fluxes (ZWF1, GND, and the ethanol synthesis
reaction) are also identified as running at or close to the conditional Vm..ax, but were not selected
by the metabolite accumulation test. Further examination shows that, compared to the candidates
selected by both tests, there is no flux imbalance around ZWF] and GND, (Figure 6), consistent
with the lack of metabolite accumulation. A more detailed study (Figure 5) shows that the
limiting metabolites for the conditional Vmax for ZWF1 and GND are carbon precursors, whereas
those for the TDH, glycerol synthesis, and TCA reactions are the co-factors NAD or NADH.
Increasing glucose input (carbon input) increases the carbon precursor levels and thus increases
the conditional Vmax for ZWF1 and GND. By contrast, the conditional Vm'ax for reactions with
NAD or NADH as the limiting cannot be released by simply increasing glucose input level.
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These reactions (TDH, glycerol synthesis, and TCA reaction) are important bottleneck
candidates for further examination.
Glucose input test detected TDH reaction as major bottleneckfor carbonflow
Ethanol is produced by converting glucose through glycolysis. For the glucose input test,
increasing amounts of glucose from 2 to 1000-fold were input and the resulting flux changes
were observed. Figure 7 shows a small a heat map of relative fluxes adjacent to each reaction
(color from white to red indicates a flux increase from negligible to large). Two patterns are clear.
Fluxes near the top of the network increase with increased input; those near the bottom remain
unchanged. In particular, the ethanol production rate does not increase with enhanced glucose
input. This phenomenon is consistent across the model ensemble and is thus not sensitive to the
parameter uncertainties. The switch of the patterns occurs on the glycolysis pathway at the TDH
reaction. Thus, TDH is identified as a bottleneck. The flux of glycerol synthesis enzyme also
does not increase with increased glucose level and appears to be another bottleneck for carbon
flow. Therefore, the glucose input test further confirms that the TDH and glycerol synthesis
reactions suggested by the metabolite accumulation and conditional Vm.a, tests are relevant
bottlenecks for ethanol production. Additional bottlenecks could exist downstream of the TDH
reaction, the effect of which could have been hidden by the effect of TDH reaction.
Decreased EO test validates TDH, glycerol synthesis reaction, and tcal as bottlenecks for ethanol
production
Sequentially observing the effect of reduced enzyme concentrations (the decreased Eo test)
was conducted to examine further the relevance of bottleneck candidates identified previously. In
particular, the Eo for TDH, glycerol synthesis, TCA1, TAL1, and NQM] were each decreased to
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80%, 50%, 10%, and 1% of their base concentration. The corresponding log ratios of the ethanol
production rates relative to those with the original Eo are plotted in Figure 8. Decreasing the Eo
(and thus the Vmnax) of TDH, glycerol synthesis, and TCA lcauses the corresponding ethanol
production rates to decrease correspondingly. This matches the intuition that decreasing the flux
capacity of a limiting reaction would further reduce ethanol production. By constast, Figure 8
shows that changes of Eo for TAL1 and NQMJ do not affect ethanol production. It indicates that
although these enzymes may be bottlenecks for the network predicted by the metabolite
accumulation and conditional Vmax tests, they are not located on the pathways affecting ethanol
production and thus are not directly relevant to the improvement of ethanol production.
Interestingly, increasing the Eo of TDH, glycerol synthesis, and TCA1 do not provide much
benefit for improving ethanol production (data not shown), which suggests that a network
solution for maximizing the ethanol yield is not obvious even if the bottleneck enzymes have
already been identified. More sophisticated techniques are needed to manipulate the network.
3.3.2 NAD and NADH balance plays a crucial role in regulating ethanol production
I mole of ethanol is produced by consuming 1 mole of pyruvate and 1 mole of NADH. The
total amount of NAD plus NADH is relatively stable and has been reported around 1-1.57mM in
cells (Chassagnole et al., 2002; Richard, Teusink, Westerhoff, & van Dam, 1993; de Koning &
van Dam, 1992). The total amount is implemented as a constant of 1.57mM in the model based
on the Chassagnole et al. model. Consequently, reduction of NAD has to be matched by a
continuous reoxidation of NADH. The ratio of NADH over NAD is crucial for ethanol
production and higher NADH/NAD ratio favors the ethanol generation. Interestingly, the
bottleneck tests described above have identified the TDH and glycerol synthesis reactions, two
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enzyme reactions much earlier than the ethanol synthesis reaction, as the major bottlenecks that
affecting ethanol production rate in the yeast central carbon metabolic network. When we
examine the ethanol production reaction alone, there is a significant shift of nicotinamide
towards the NADH format after switching from aerobic to anaerobic condition and most of the
models have NADH as the dominant form (Figure 9). This major increase of NADH level
matches well with the significant increase of ethanol production in the anaerobic condition as
shown in Figure 9. Under aerobic condition, the NADH formed by TDH reaction is ultimately
reoxidized to NAD by passage of its electrons to 02 in mitochondrial respiration. However,
under anaerobic condition, NADH generated by glycolysis cannot be reoxidized by 02. Failure
to regenerate NAD would leave the cell with no electron acceptor and thus stop the glycolysis
pathway (Nelson & Cox, 2008). The pyruvate metabolism is thus switched from going towards
the TCA cycle which also requires NAD as reactant to going towards the ethanol synthesis
pathway which regenerates NAD by accepting the electrons. It is impressive that the models can
automatically capture this oxygen condition change and switch the pyruvate consumption
pathway accordingly. As mentioned in the conditional Vmax test, some models have the carbon
precursor, pyruvate, instead of the NADH as the limiting precursor for the ethanol production
reaction. How much pyruvate the downstream pathway can acquire, as pointed out by the
glucose input test, depends on the flux capacity of the TDH reaction. The conditional Vmax test
for the TDH reaction indicates that the limiting factor for the capacity of this reaction is the NAD
level in the system. Based on these analyses, the NAD and NADH balance is crucial for
determining the ethanol production rate in the system. A higher NAD to NADH ratio could
release the limitation of the TDH reaction and thus increase the carbon converted to pyruvate; on
the other hand, a lower NAD to NADH ratio would favor the ethanol synthesis reaction goes
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towards the ethanol production. The NADH generated by TDH and TCA reactions are consumed
by ethanol synthesis and glycerol synthesis reactions. The faster the ethanol synthesis reaction
runs, the more NAD gets recycled, and thus the faster the TDH reaction runs, until the NADH
has been consumed so much that it starts to become the limiting precursor instead of pyruvate.
At the anaerobic pseudo-steady state observed in the model ensemble, there is a shift towards the
NADH format, which reduces the capacity of the TDH reaction and limits the pyruvate available
for ethanol production. For ethanol production, the availability of NADH and pyruvate is inter-
connected. A careful network flux control is needed to balance the precursors and maximize the
productivity.
The glycerol synthesis reaction also plays an important role in ethanol production. As the
generation of glycerol from DHAP converts NADH to NAD, it helps release the TDH bottleneck
by providing more NAD. However, as indicated by the conditional Vmax test, the glycerol
synthesis reaction may be already running at the overall Vm.ax. This means the glycerol synthesis
reaction already recycles NAD at its maximum capacity, and it cannot further help release the
TDH bottleneck. On the other hand, glycerol is usually considered as an unwanted side-product
for ethanol production. It has been estimated that elimination of glycerol production in industrial
yeast fermentations aimed at the production of alcohol might increase the annual worldwide
production of ethanol by 1.25 billion liters (Nissen et al., 2000). Therefore limiting the glycerol
reaction rate is usually desired in industry productions (Bakker et al., 2001). A flux control that
balances the benefit of releasing the TDH bottleneck and limiting the glycerol yield is desired to
maximize the ethanol industrial yield.
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3.3.3 Sequential bottleneck release increases ethanol production yield
The NAD and NADH inter-conversion is involved in multiple reactions in the central carbon
metabolic network and controls the yield of ethanol against glucose and glycerol. As discussed in
previous session, a careful control of the NAD to NADH balance is desired in order to achieve
the maximum ethanol production rate. However, due to the complicated inter-dependency of the
NAD/NADH related reactions, it is not obvious how to adjust the enzyme levels of each reaction
to optimize the network performance. A sequential single enzyme over- and under-expression
optimization was conducted on each enzyme and each model. When applied the first round of
single enzyme optimization, multiple optimization strategies have been identified that improve
the ethanol production. The maximum ethanol production yields for each model with single
enzyme optimization are shown in Figure 10. The models are ordered based on their wild-type
ethanol yield against glucose (blue bars). Enzyme strategies that are elected by more than one
model are marked out in different colors. 88.5% of the models in the ensemble have a wild-type
ethanol yield between 75-80% of the theoretical yield, which is similar to the reported
production from Saccharomyces cerevisiae (Nevoigt, 2008). The enzyme names and average
modulation ratios that lead to the best ethanol production rate for the models are listed in Table
2A.
The over-expression of the ethanol synthesis enzyme (EOLE) is the most popular strategy
which is elected as the best for 30 of the 52 models in the ensemble. In fact, over-expressing
EOLE improves the ethanol production in all the 52 models, although the effects are very mild
for some models. Recall that the ethanol synthesis enzyme is identified as running close to the
overall Vmax for many models based on the conditional Vmax test. An over-expression of this
enzyme for those models could increase the capacity of this reaction and allows higher flux.
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Indeed the ethanol synthesis fluxes of the models elected EOLE as the best strategy are on
average 13.9% closer to their corresponding conditional Vmax. Previously, the ethanol synthesis
reaction is not defined as a network bottleneck, mainly because it is only identified by the
conditional Vmax test but no major metabolite accumulation observed. However, we discussed
that under the anaerobic condition, there is a shift towards the NADH form compared to the
NAD form, and most of the nicotinamide exists in the NADH form for many models. This can
be considered as a type of metabolite accumulation of the NADH as well. The constant level of
NAD plus NADH of a mild 1.57mM made it hard to observe through the metabolite
accumulation test. Here, we would therefore define the EOLE reaction as another network
bottleneck. In previous discussion we mentioned that a faster ethanol production reaction can
lead to more NADH recycled to NAD which, in return, releases the TDH bottleneck for more
downstream pyruvate. The release of TDH bottleneck by EOLE over-expression can be indeed
observed in Figure 11 which shows that for all the models having metabolite accumulation
problem, the accumulations of F 1,6P, G3P, and DHAP that represent the TDH bottleneck have
been released. Figure 12, which plots the reaction rates of TDH and ethanol synthesis reaction
before and after applied the EOLE over-expression strategy, confirms that the increased EOLE
reaction rate does help increase the TDH flux and thus release the bottleneck. Under-expressing
glycerol synthesis enzyme (GL CE) is also selected by 4 models. The metabolite accumulation
test for these 4 models displays no obvious accumulation for any metabolites, which indicates no
significant bottleneck in these models. Under-expressing GLCE limits the NADH reoxidized by
glycerol synthesis reaction and thus could increase the NADH level in the system. The NADH
concentration indeed increased by 10% to 12-fold for these 4 models after applied GLCE under-
expression. The corresponding ethanol reaction and TDH reaction are increased for 8.6% and
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5.0%, respectively. The glucose transporter (GT) over-expression and CDC19 over-expression
are also selected by 4 and 3 models, respectively, which potentially increase the carbon
availability for the downstream ethanol pathway. Other strategies have relatively fewer
supporting models, which reflect the affects of parameter uncertainties on strategy selection.
After the first round of single enzyme optimization, the ethanol yields of many models are
enhanced to 80-90% of the theoretical yield (Figure 10) and all models have found at least one
strategy to improve their ethanol yields. A second round of single enzyme over- and under-
expression optimization was conducted based on the improved models from the first round.
Further benefit for ethanol yield is achieved. 57.7% models now have ethanol yield beyond 90%
of the theoretical yield (73.3% of them have ethanol yield beyond 95%) compared to only 15.4%
after the first round optimization (Figure 13). All but one model chooses a different enzyme
strategy than the first round. It indicates the first enzyme strategy already achieves the best
benefit it can lead to and it needs a manipulation of a different enzyme to achieve further
improvement. The strategies selected by the second round optimization are listed in Table 2B.
The CDC19 over-expression, which increases the conversion from PEP to PYR, is the most
elected strategy for the second round optimization. It may indicate that after the EOLE
bottleneck release, it now can use more carbon resources from the upstream network. It is
interesting that the over-expression of the bottleneck enzyme TDH is only elected by one model
in the first round and 3 model in the second round, which suggests that a direct over-expression
of the bottleneck enzyme may not be the most efficient strategy to improve the network
production. It may become significant after more optimization rounds when some other
bottlenecks have been released first. This also illustrates the complexity and difficulty when
there are multiple bottlenecks in the network that there may be an optimal order to release
Ill
different bottlenecks. The order of these strategies may not be obvious and require computational
modeling to reveal the best recipe. For the second round optimization, the EOLE, GT, and some
other strategies show up again as popular strategies. Although coming in different orders for
different models due to the parameter uncertainties, it seems an exhaustive experimental test for
the combinations of four or five enzymes (EOLE, CDC19, GT, GLCE) would have a high
likelihood to result in the best improvement of the ethanol production. Further round of
optimizations can be conducted until it meets the ethanol yield requirement or no further
improvement can be acquired.
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3.4 Conclusions
There have been many practices using the experimental methods to detect the bottlenecks of
the metabolic networks, most of which involves detecting accumulated metabolites in the system
or randomly increasing the E0 of the enzymes on the direct pathway. These approaches are
usually time consuming and do not always generate biological insights, as enhanced production
of target chemicals caused by increased enzyme Eo does not directly indicate those enzymes are
bottleneck, because there may be other intrinsic bottlenecks get released by the increased Eo of
those enzymes. Many times, there are multiple bottlenecks in the network, without uncover all of
which, it is difficult to design strategies to achieve the best production. In this report, we
demonstrated a computational framework which can systematically identify bottlenecks in the
system with very limited data. In particular, TDH reaction, which is much earlier in the pathway
than the step of ethanol production, is detected as one of the major bottlenecks for ethanol
production in the central carbon metabolic network. The metabolite accumulation test shows
significant accumulation of precursors of the TDH reaction and glucose input test indicates TDH
reaction limits the carbon flow towards the downstream pathway (e.g., ethanol production). The
conditional Vmax test further suggests the NAD is the limiting factor for the TDH reaction. Our
study further indicates that the NAD and NADH balance is determined by several key reactions,
including TDH, ethanol synthesis reaction, glycerol synthesis reaction, TCA reactions, etc. and
the concentration ratio between NAD and NADH is a crucial regulator of the ethanol production
rate. In particular, the ethanol production requires two precursors, the carbon precursor pyruvate
and the NADH. Our analysis shows that the NADH and pyruvate concentrations are inter-
dependent, as higher NADH level leads to lower NAD level for TDH reaction and thus fewer
carbon available for downstream pathway. It is thus not obvious of how to manipulate the
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enzyme levels in the network in order to maximize the ethanol production. We presented a
sequential single enzyme optimization method to identify strategies that gradually release
network bottlenecks and increase the ethanol production yield. The over-expression of ethanol
synthesis enzyme is elected as one of the most popular strategies for the first round optimization,
which is consistent with the result that the ethanol production reaction has reached overall Vma,
and is also a major bottleneck for many models. Interestingly, CDC19 is selected as the most
efficient strategies for the second round of optimization, which indicates different strategies are
usually desired to further improve the production after releasing the first bottleneck. After two
rounds of single enzyme over- and under-expression optimization, 57.7% of the models in the
ensemble have reached over 90% of the theoretical ethanol production yield and all models have
improved ethanol production, compared to 70-80% of the theoretical yield for all wild-type
models. The model ensemble we built covers the parameter uncertainties introduced by fitting
the experimental data. Although different strategy orders are suggested for different models, a
similar set of strategies is elected for the first round and second round optimizations. Therefore,
an exhaustive experimental test of a limited set of enzyme strategies would lead to a high
likelihood to secure the most efficient strategies to achieve the best ethanol production yield. The
yeast central carbon metabolic network model we constructed here can be easily extended to
study other academically or commercially interesting chemicals, e.g. high carbon biofuel, etc.,
which are directly or indirectly linked to the glycolysis or pentose phosphate pathway. The four-
test bottleneck detection framework we developed demonstrated as an efficient technique to
discover valuable insights for network re-engineering before complicated experiments are
required.
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Figure 1. NAD and NADH dynamics in central carbon metabolic network. The blue blocks
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pathways are mainly responsible for reoxidizing NADH under anaerobic condition.
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Tables
Enzyme reactions Functions Reaction mechanisms
TDH NAD to NADH G3P + NAD * PGP + NADH
PDB1 NAD to NADH PYR + NAD ACCOA + NADH
TCA1 NAD to NADH OXA + ACCOA + NAD * KG + NADH
TCA2 NAD to NADH KG + NAD * SCOA + NADH
TCA3 NAD to NADH SCOA + NAD* OXA + NADH
OPE NADH to NAD NADH + / O2- NAD + H20
EOLE NADH to NAD PYR + NADH-+ EOL + NAD
GLCE NADH to NAD DHAP + NADH- Glycerol + NAD
Table 1. Reaction mechanisms used to update NAD/NADH and NADP/NADPH balances. The
full names of the enzymes and metabolites can be found in Abbreviations session.
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A
Strategy name Number of models Modulation ratio
EOLE 30 22.7
GLCE, GT 4 0.07, 2.7
CDC19 3 40.3
TPI], TCA1 2 25.0, 29.1
TDH, PGI, RKIJ, TCA2, 1 12.0, 3.6, 32.2, 41.0,
OPE, PYRD 0.02, 0.02
B
Strategy name Number of models Modulation ratio
CDC19 11 45.7
EOLE 9 23.1
GT 5 2.0
TDH 3 24.0
TPI], PGI, PFK], TCA] 2 27.0, 45.5, 50, 30.5
ENO, PGM, PDB1, G1PAT, 50, 0.02, 0.04, 0.02, 38.8, 1.2,
NQMI, TCA2, GLCE, DEG, 1 2.4, 0.02, 0.02
PYRD
Table 2. Best enzyme strategies from the sequential single enzyme over- and under-expression.
A. the enzyme strategies from the first round optimization; B. the enzyme strategies from the
second round optimization. The first column shows the strategy name. The second column shows
the number of models elected the corresponding strategies. The third column shows the average
modulation ratio for the corresponding enzymes, with number above 1 for over-expression and
number below I for under-expression.
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Abbreviations
Enzymes
FBA
DAHPS
ENO
GIPA T
GLCE
TDH
metSynth
MUR
PFK
GND
PGII
PGK1
PDB1
PGM
PYK
RKI1
RPPK
RPE1
TA L
TPI]
TKL
trpSynth
Metabolites
2pg
3pg
6pg
accoa
e4p
f6p
fl,6p
gip
g6p
g3p
ile
lala
kival
dipim
nad
nadh
nadp
nadph
Aldolase
DAHP synthases
Enolase
Glucose-i-phosphate adenyltransferase
Glycerol-3-phosphate dehydrogenase
Glyceraldehydes-3-phosphate dehydrogenase
Methionine synthesis
Mureine synthesis
Phosphofructokinase
6-phosphogluconate dehydrogenase
Glucose-6-phosphate isomerase
Phosphoglycerate kinase
Pyruvate dehydrogenase
Phosphoglucomutase
Pyruvate kinase
Ribose-phosphate isomerase
Ribose-phosphate pyrophosphokinase
Ribulose-phosphate epimerase
transaldolase
Triosephosphate isomerase
Transketolase
Tryptophan synthesis
2-phosphoglycerate
3-phosphoglycerate
6-phosphogluconate
Acetyl-coenzyme A
Erythrose-4-phosphate
Fructose-6-phosphate
Fructose-1,6-bisphosphate
Glucose-I -phosphate
Glucose-6-phosphate
Glyceraldehydes-3-phosphate
Isoleucine
L-alanine
Alpha-ketoisovalerate
Diaminopimelate
Diphosphopyridindinucleotide, oxidized
Diphosphopyridindinucleotide, reduced
Diphosphopyridindinucleotide-phosphate, oxidized
Diphosphopyridindinucleotide-phosphate, reduced
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pep Phosphoenolpyruvate
pyr Pyruvate
r5p Ribose-5-phosphate
ru5p Ribulose-5-phosphate
s7p Sedoheptulose-7-phosphate
x5p Xylulose-5-phosphate
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Chapter 4
Conclusions and future directions
The rapid development of genome sequencing and high-throughput measurement techniques of
enzymes and species concentrations has the potential to bring the biological sciences into the era
of so-called 'big-data'. The large amount of available data for concentrations, fluxes, and
kinetics of enzymes under normal or perturbed conditions in biological networks provide
unprecedented opportunities to understand the functional mechanisms of cells. On the other hand,
it brings new challenges of handling, integrating, and interpreting the large amount of data to
acquire novel biological knowledge. With the development of computational and systems
biology, it is now commonly believed that system-level modeling may provide unique
opportunities to understand cellular function. New techniques for modeling biological networks,
which can incorporate the vast amount of available data and describe the underlying biochemical
mechanisms, are needed. It is also important to develop methodologies to analyze intrinsic
network properties and optimize system behavior to fit desired performance.
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In this thesis, I presented new ordinary differential equation (ODE) models of central carbon
metabolism for E. coli and S. cerevisiae based on mass-action rate laws (MRL) of the
biochemical reactions. They describe actual biochemical mechanisms of the enzyme reactions,
e.g., the binding and releasing of reactants, the conversion from reactant-enzyme complex to
product-enzyme complex, and the binding and release of the products, using separate kinetic
parameters. Therefore, it reflects closely of how real enzymes work and has the potential to
guide protein engineering. If well trained, the models can help predict the most efficient ways to
modify single enzymes, e.g. improving reactant binding, improving kcat, or improving product
release, in order to achieve a better level of network performance. Because the MRL models are
constructed with elementary enzyme reaction steps, it is much easier than in aggregated rate law
(ARL) models to incorporate new enzyme interactions and regulation, which makes this model
type very flexible to be extended for studying a different aspect of the same network. This point
is demonstrated in this thesis by converting the E. coli model from Chapter 2 to the
Saccharomyces cerevisiae model in Chapter 3. The new model includes the important new
features such as the oxygen dynamics, the automatic switch from aerobic to anaerobic condition,
and NAD/NADH balance, but it only requires minor changes of several elementary reaction
mechanisms. On the other hand, the ARL models would require updated aggregated reaction
formula incorporating the effect of the new co-factors. The modifications are not straightforward
as many reactions use empirical formula based on experiments with little theoretical rationale.
With new measurement data becoming available, the model can be easily re-fit to any new
concentration, fluxes, or enzyme kinetic data to refine the performance. This point is
demonstrated by re-fitting the E. coli model with new S. cerevisiae data in Chapter 3. The high
flexibility and mechanistically realistic features of the mass-action ODE models make it an
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attractive technique to model important biological systems, such as the highly conserved central
carbon metabolic network and gene expression regulatory networks.
The issue of parameter uncertainties exists for almost all modeling work, due to incomplete data
and lack of biological knowledge. In this thesis, we handle the parameter uncertainty problem by
introducing model ensembles. Multiple parameter values that fit equally well to the measured
data can be found. Instead of using one single model that best fits the available data to make
predictions, we collected a group of models based on proper sampling methodologies and use the
model ensemble to draw more reliable conclusions. The models in the ensemble all share the
same topology but have different parameter values. Without further experimental data, there is
no basis for choosing a single parameter set that represents the best biology. It is especially true
when it considering mutant networks that a good wild-type parameter set may not necessarily
represent the correct behavior after enzyme mutations or expression changes are applied. We
observed some inconsistency in predictions from the models in the ensemble from the studies
both in Chapter 2 and Chapter 3. It illustrates the significant impact of parameter uncertainty on
model predictions and demonstrates the risks of using a single model to draw conclusions with
limited data. In Chapter 2, we assign equal weight to each model and let them vote for the best
enzyme strategies that optimize the aromatic amino acid productions. If a high percentage of
models agree on certain strategies, we have more confidence in them as they are less sensitive to
parameter uncertainties existing in the models. It thus provides a way to evaluate the robustness
of different enzyme strategies and can potentially improve success rates when applying the
predicted strategies to experiments and industrial production. Compared to mathematical
methods (e.g., uncertainty propagation) to evaluate parameter uncertainties, the model ensemble
method is more straightforward to understand and thus easier to communicate with
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experimentalists. It could also be more accurate in many situations given the highly non-linear
properties of biological networks. Theoretically, the more models to be included in the ensemble,
the better coverage there could be for the parameter space. However, available computational
power could limit how many models it is feasible to incorporate into the ensemble. More
sophisticated technologies for uncertainty control should be developed in the future to more
efficiently handle the predictions from mass-action rate law ODE models.
The central carbon metabolic network is one of the most studied biological networks. It has
many good features as a case study to develop computational methodologies (e.g., the well
known topology, the known kinetics for many enzymes in this network, and large data set of
measured data). On the other hand, the complicated enzyme interactions and regulations in
central carbon metabolism also make it a challenging network to analyze and interpret with
computational models. Of the different properties we can learn about a network, bottleneck
analysis is one of the most important ones, because the increasing use of computational models
in metabolic engineering studies that aim to improve production rates of target chemicals.
However, limited research has been done in systematically identify bottlenecks in the central
carbon metabolic network. In Chapter 3 we developed a bottleneck identification framework,
composed of four computational tests, (i.e., metabolite accumulation, conditional Vmax, glucose
input, and decreased Eo). This framework is shown to efficiently identify relevant bottlenecks
limiting ethanol productions. In particular, the conditional Vmax test can directly determine the
utilization of available enzyme capacity at a given system state. More importantly, it can provide
valuable insights into the intrinsic rationale for the observed rate-limiting steps. Based on these
analyses, it is suggested that the balance between NAD and NADH molecules, determined by the
relative fluxes of eight enzyme reactions, is the crucial limiting factor for ethanol production.
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The TDH and ethanol synthesis reactions are two important bottlenecks in the network that
constrain the improvement of ethanol yield. Although the bottleneck identification framework
was developed and applied to the central carbon metabolic network, the concepts have general
value and can be applied to other metabolic networks.
Due to the complexity of central carbon metabolism, it is not obvious of how to manipulate the
network for optimized target production, even if we may have gained the knowledge of
bottlenecks in the network. In Chapter 2, we showed that aromatic amino acid production
requires two precursors, E4P and PEP, one from the pentose phosphate pathway and the other
from the glycolysis pathway. There are several branching points between the pentose phosphate
pathway and glycolysis. It is not immediately clear how to manipulate the network in order to
achieve balanced production of these two metabolites. In Chapter 3 we showed that there is a
trade-off between the production of two precursors, pyruvate and NADH, of ethanol synthesis.
Due to the constant level of total NAD plus NADH, more NADH means less NAD in the system,
which in return, limits the TDH reaction rate and thus the availability of pyruvate to the ethanol
synthesis pathway. Six other enzyme reactions also contribute to the balance of NAD and NADH
in the system. It is not straightforward to identify the right strategies to balance the precursors for
best ethanol production. In this thesis, we developed an optimization methodology for mass-
action rate law ODE models that allows parallel or sequential combinations of enzyme knock-out
and over-/under-expression strategies to the model in order to search for the enzyme strategies
that optimize target production rates. The method is shown to be efficient and reliable, with
many of the suggested strategies tested to be positive through previous experiments. More
strategies that are never considered by previous researches are also predicted by the optimization
results, which serve as useful guidance for future experimental design. Results from
143
experimental tests, whether successful or not, can be used to further refine the parameters of the
model or the composition of the ensemble. It can be expected cycles of prediction and testing
will lead to improved performance of computational models.
In this thesis, the two applications are both in the field of metabolic engineering, in which
optimization of the target chemical production is the major objective. However, the scope of
applications in which these types of models could be used is much broader. Recently there is
increasing interest in cancer metabolism, which suggests potential links between cancer
development and aerobic glycolysis. Decades ago, the Warburg effect described the increased
utilization of the glycolysis pathway under aerobic condition for cancer cells compared to normal
ones (Warburg, 1956). Since then, significant work has been conducted trying to determine the
causal relation between cancer development and abnormal flux in the glycolysis pathway (Fantin
et al., 2006; Hsu & Sabatini, 2008; Kroemer & Pouyssegur, 2008). Interestingly, the
NAD/NADH ratio has been identified as an important factor connecting central metabolism with
cancer cells (Koukourakis et al., 2006). Thus, it is possible that central carbon metabolism
models built from those described in this thesis, especially the NAD/NADH involved models
described in Chapter 3, can be used to understand cancer mechanism. A bridge between
mechanistic models of central carbon metabolism and higher-level cancer progression processes
needs to be found for the purpose of this study. As described in Chapter 1, some preliminary
research has been conducted where we adopted a commonly used cancer progression model and
defined the mutation rates of that model to depend on the output of the mechanistic models that
describe the selenium metabolism. The preliminary results of this combined model show the
variations of the cancer progress rates for different selenium input, which indicates that we can
indeed construct a cancer progression model that depends on detailed mechanistic models. With
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this proof-of-concept test on the simplified selenium metabolism model, it is expected that it
would be possible to incorporate the entire central carbon metabolism model with the cancer
progression model (for example using NAD/NADH ratio as a linker for the two models).
Significant impact can be anticipated for the application of this combined model. It can be used
to understand whether changes in central metabolism can speed up cancer progression, and
whether the development of cancer requires the enhanced glycolysis pathway to provide the
'building blocks'. Clinical trial simulations can be built on top of the combined model, so that it
is possible to identify possible therapies that reduce the cancer progression rate. With the
increasing availability of experimental and clinical data, the mass-action rate law models we
built here, and especially the methods developed and applied, will surely make a great impact on
biomedicine and metabolic engineering.
References
Fantin, V. R., St-Pierre, J., & Leder, P. (2006). Attenuation of LDH-A expression uncovers a
link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell,
9(6), 425-34. doi: 10.101 6/j.ccr.2006.04.023
Hsu, P. P., & Sabatini, D. M. (2008). Cancer cell metabolism: Warburg and beyond. Cell, 134(5),
703-7. doi: 10.101 6/j.cell.2008.08.021
Koukourakis, M. I., Giatromanolaki, A., Harris, A. L., & Sivridis, E. (2006). Comparison of
metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a
metabolic survival role for tumor-associated stroma. Cancer Research, 66(2), 632-7.
doi:10.1158/0008-5472.CAN-05-3260
Kroemer, G., & Pouyssegur, J. (2008). Tumor cell metabolism: cancer's Achilles' heel. Cancer
Cell, 13(6), 472-82. doi: 10.101 6/j.ccr.2008.05.005
Warburg, 0. (1956). On the origin of cancer cells. Science, 123(3191).
145
Appendix A
Enzyme reaction mechanisms in E. coil mass-action model
F6P + Mur± Mur:F6P -+ murine + Mur
<}-- PYR
RPIA + Ru5Pi± RPIA:Ru5P:± RPIA:R5PW± R5P + RPIA
RPIB + Ru5P2W± RPIB:Ru5P2W± RPIB:R5PW± R5P + RPIB
RPE + Ru5P± RPE:Ru5PW± RPE:X5P:± RPE + X5P
R5P + TKTAW± TKTA:R5P
X5P + TKTA:R5P:± TKTA:R5P:X5P *± TKTA:S7P:G3Pi± S7P + TKTA:G3P
TKTA:G3Pi± G3P + TKTA
X5P + TKTAM± TKTA:X5P
E4P + TKTA:X5P2W± TKTA:X5P:E4Pi± TKTA:F6P:G3P4± F6P + TKTA:G3P
R5P + TKTBiL TKTB:R5P
X5P + TKTB:R5Pi± TKTB:R5P:X5PW± TKTB:S7P:G3PW± S7P + TKTB:G3P
TKTB:G3P~-± G3P + TKTB
X5P + TKTB-± TKTB:X5P
E4P + TKTB:X5P2i± TKTB:X5P:E4Pi-± TKTB:F6P:G3Pi± F6P + TKTB:G3P
G3P + TALAj± TALA:G3P
S7P + TALA:G31W* TALA:G3P:S7PW± TALA:E4P:F6PW± E4P + TALA:F6P
TALA:F6P2-± F6P + TALA
G3P + TALBi± TALB:G3P
S7P + TALB:G3P2± TALB:G3P:S7P TALB:E4P:F6P E4P + TALB:F6P
TALB:F6P4-- F6P + TALB
R5P + RPPKW RPPK:R5P-* nucleotide + RPPK
DHAP + G3PDHM G3PDH:DHAP* glycerol + G3PDH
3PG + SerSynth W± SerSynth:3PG -* serine + SerSynth
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PEP + Synth 1*± Synth :PEP -> chomur + SynthI
PYR + Synth2i± Synth2:PYR-* ile + Synth2
G6P + ZWFi± ZWF:G6P 2W ZWF:GL6P-* GL6P + ZWF
GL6P + PGLi PGL:GL6P-* PGL + 6PG
6PG + GND al GND:6PG-+ Ru5P + GND
DHAP + TIS2-± TIS:DHAPi± TIS:G3PW± G3P + TIS
3PG + GPMA -± GPMA:3PG-± GPMA:2PGW± 2PG + GPMA
3PG + GPMB--± GPMB:3PGaW GPMB:2PG-± 2PG + GPMB
G6P + PGM :±PGM:G6P--± PGM:G1Pi± GIP + PGM
2PG + ENOif ENO:2PGt± ENO:PEP4- PEP + ENO
G3P + GAPA;± GAPA:G3Pi± GAPA:PGPi± PGP + GAPA
PGP + PGK i PGK:PGPW PGK:3PG -3PG + PGK
FI,6P + FBAA2I FBAA:F1,6P*± FBAA:DHAP:G3P4± G3P + FBAA:DHAP
FBAA:DHAPi± DHAP + FBAA
F1,6P + FBAB27* FBAB:F1,6P--± FBAB:DHAP:G3PW± G3P + FBAB:DHAP
FBAB:DHAP;f DHAP + FBAB
PYR + PDHW± PDH:PYR_- * accoa + PDH
PYR + PDH:PYR_1+± PDH:PYR_2 -- accoa + PDH:PYR_1
PYR + PDH:PYR_2;± PDH:PYR_3-p accoa + PDH:PYR_2
PYR + PDH:PYR_3* ± PDH:PYR_4-* accoa + PDH:PYR_3
E4P + DHAPS002Z DHAPS10
PEP + DHAPSO 2± DHAPSO1
E4P + DHAPSO 1lW± DHAPS 11
PEP + DHAPSO1t DHAPSO2
E4P + DHAPSO24± DHAPS12
E4P + DHAPS10 DHAPS20
PEP + DHAPS1O± DHAPS1 1
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E4P + DHAPS1 1 ± DHAPS21
PEP + DHAPS114 DHAPS12
PEP + DHAPS20i± DHAPS21
E4P + DHAPS12:± DHAPS22
PEP + DHAPS21I± DHAPS22
DHAPS22-* S3P + DHAPS1 1
F1,6P + PPCO± PPCl
PEP + PPCOMi PPCOA-+ oaa + PPCO
F1,6P + PPC1± PPC2
PEP + PPC12i± PPC1A-+ oaa + PPC1
F1,6P + PPC2:a± PPC3
PEP + PPC2i± PPC2A-- oaa + PPC2
F1,6P + PPC3i PPC4
PEP + PPC3;± PPC3A-+ oaa + PPC3
PEP + PPC4i PPC4A-* oaa + PPC4
F1,6P + GIPATOi± GIPATI
F1,6P+GIPAT1g± GlPAT2
GIP + GlPA TOi± G1PATOA -+ PolySac + GIPATO
GIP + GlPAT*-± G1PATA-+ PolySac + GIPATI
GIP + GlPAT2W± GIPAT2A -* PolySac + GIPAT2
G6P + PGI W±PGI:G6P4± F6P + PGI-± PGI:F6P
6PG + PGIi± PGI:6PG
6PG + PGI:6PG2i± PGI:6PG:6PG
F6P + PGI:6PG2i± PGI:6PG:F6P2-± G6P + PGI:6PG-± PGI:6PG:G6P
F6P + PFKA_0_0i± PFKA_1_0-* F1,6P + PFKA_0_0
F6P + PFKA_1_0± PFKA_2_0-+ FI,6P + PFKA_1_0
F6P + PFKA_2_0W± PFKA_3_0--+ F1,6P + PFKA_2_0
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F6P + PFKA_3_0± PFKA_4_0-+ F1,6P + PFKA_3_0
F6P + PFKA_4_0± PFKA5_0-+ F1,6P + PFKA_4_0
F6P + PFKA_5_0:± PFKA_6_0-+ F1,6P + PFKA_5_0
F6P + PFKA_6_02± PFKA_70 -* F1,6P + PFKA_6_0
F6P + PFKA_7_0± PFKA_8_0-* F1,6P + PFKA_7_0
F6P + PFKA_8_0± PFKA_9_-+ F1,6P + PFKA_8_0
F6P + PFKA_9_0 W PFKA_10_0-* F1,6P + PFKA_9_0
F6P + PFKA 10_ 0± PFKA_1 _0 -+ F1,6P + PFKA 10_0
Repeat the above for PFKB
PEP + PFKA_0_04- PFKA_0_1
PEP + PFKA_0_1±- PFKA_0_2
PEP + PFKA_0_2i± PFKA_0_3
PEP + PFKA_0_3:± PFKA_0_4
F1,6P + FBP -Z FBP:F6Pi± F6P + FBP
PEP + PYKF00 PYKF10-* PYR + PYKFOO
PEP + PYKF10 ± PYKF20-* PYR + PYKF 10
PEP + PYKF202i± PYKF30-* PYR + PYKF20
PEP + PYKF3024± PYKF40-* PYR + PYKF30
PEP + PYKFO I PYKF1 1- PYR + PYKFO1
PEP + PYKF11 ±PYKF21-+ PYR + PYKF11
PEP + PYKF2 1-± PYKF3 1-* PYR + PYKF21
PEP + PYKF3 1;w± PYKF41 -* PYR + PYKF31
F1,6P + PYKF002W± PYKFO1
Repeat above for PYKA
PYR + PPSA ± PPSA:PYR * PPSA:PEP * PEP + PPSA
PEP + PTS i PTS:PEP
GIcEx + PTS:PEP2i± PTS:GlcEx:PEP-+ PYR + PTS:G6P
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PTS:G6P-* G6P + PTS
PYR + PTSi± PTS:PYR
G6P + PTS2W± PTS:Il
G6P + PTS:I1W± PTS:12
G6P + PTS:I22± PTS:13
G6P + PTS:I34W PTS:14
G6P + PTS:PEPW PTS:PEP:Il
G6P + PTS:PEP:IlW± PTS:PEP:12
G6P + PTS:PEP:I2W± PTS:PEP:13
G6P + PTS:PEP:I32-± PTS:PEP:14
G6P + PTS:PYR*± PTS:PYR:Il
G6P + PTS:PYR:Iit PTS:PYR:12
G6P + PTS:PYR:I24± PTS:PYR:13
G6P + PTS:PYR:I3W± PTS:PYR:14
G6P + PTS:GlcEx:PEPi± PTS:GlcEx:PEP:Il
G6P + PTS:GlcEx:PEP:I 1 PTS:GlcEx:PEP:12
G6P + PTS:GlcEx:PEP:I2i± PTS:GlcEx:PEP:I3
G6P + PTS:GlcEx:PEP:I3:± PTS:GlcEx:PEP:14
6PG + EDDW EDD:6PG- EDD:2KDPG4 2KDPG + EDD
2KDPG + EDAW± EDA:2KDPGW± EDA:PYR:G3PW± G3P + EDA:PYR
EDA:PYR i PYR + EDA
S3P + E1lW± E1:S3P
PEP + E1:S3Pi± E1:S3P:PEP* PYR + EI:13G
E1:13G-* 13G + El
13G + E2 *± E2:13G -* G3P + E2
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Appendix B
Enzyme reaction mechanisms in Saccharomyces cerevisiae mass-action model
F6P + Mur± Mur:F6P -+ murine + Mur
<-* PYR
RPIA + Ru5P2 ± RPIA:Ru5PW± RPIA:R5P2i± R5P + RPIA
RPIB + Ru5Pi± RPIB:Ru5P?-± RPIB:R5P2W± R5P + RPIB
RPE + Ru5Pi± RPE:Ru5Pi± RPE:X5PW± RPE + X5P
R5P + TKTA2i± TKTA:R5P
X5P + TKTA:R5Pi± TKTA:R5P:X5P i± TKTA:S7P:G3PW± S7P + TKTA:G3P
TKTA:G3P2j± G3P + TKTA
X5P + TKTAi± TKTA:X5P
E4P + TKTA:X5Pj± TKTA:X5P:E4P4± TKTA:F6P:G3P± F6P + TKTA:G3P
R5P + TKTBi TKTB:R5P
X5P + TKTB:R5PW TKTB:R5P:X5Pi± TKTB:S7P:G3Pi± S7P + TKTB:G3P
TKTB:G3P2W1 G3P + TKTB
X5P + TKTB± TKTB:X5P
E4P + TKTB:X5PW± TKTB:X5P:E4P± TKTB:F6P:G3Pi± F6P + TKTB:G3P
G3P + TALA± TALA:G3P
S7P + TALA:G31W* TALA:G3P:S7PM± TALA:E4P:F6PW E4P + TALA:F6P
TALA:F6PW± F6P + TALA
G3P + TALB*± TALB:G3P
S7P + TALB:G3P± TALB:G3P:S7P* TALB:E4P:F6P E4P + TALB:F6P
TALB:F6PW± F6P + TALB
R5P + RPPK* RPPK:R5P-*nucleotide + RPPK
NADH + GLCE:± GLCE:NADH
DHAP + GLCE:NADHi± GLCE:NADH:DHAP-* GLCE:Glycerol + NAD
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GLCE:Glycerol1d Glycerol + GLCE
3PG + SerSynth i SerSynth:3PG -* serine + SerSynth
PEP + Synthl 2i± Synth :PEP -* chomur + SynthI
PYR + Synth2W± Synth2:PYR-* ile + Synth2
NADP + ZWFi± ZWF:NADP
G6P + ZWF:NADPi± ZWF:NADP:G6Pi± ZWF:NADPH:GL6PjM NADPH + ZWF:GL6P
ZWF:GL6P± ZWF + GL6P
GL6P + PGLW± PGL:GL6P-* PGL + 6PG
NADP + GND i± GND:NADP
6PG + GND:NADPW± GND:NADP:6PG-* NADPH + GND:Ru5P
GND:Ru5Pi± Ru5P + GND
DHAP + TISi± TIS:DHAPW± TIS:G3P2W± G3P + TIS
3PG + GPMAW GPMA:3PGi± GPMA:2PGW± 2PG + GPMA
3PG + GPMBW± GPMB:3PG W GPMB:2PGi± 2PG + GPMB
G6P + PGM ±PGM:G6P--± PGM:GlP:± GIP + PGM
2PG + ENOW± ENO:2PG± ENO:PEPi± PEP + ENO
NAD + GAPAW± GAPA:NAD
G3P + GAPA:NADw± GAPA:NAD:G3Pi± GAPA:NADH:PGP*± NADH + GAPA:PGP
GAPA:PGPi GAPA + PGP
G3P + GAPAj± GAPA:G3Pi± GAPA:PGPi± PGP + GAPA
PGP + PGK 4 PGK:PGP W PGK:3PG i±3PG + PGK
F1,6P + FBAA2i± FBAA:F1,6P2-± FBAA:DHAP:G3PW± G3P + FBAA:DHAP
FBAA:DHAPW± DHAP + FBAA
F1,6P + FBABW± FBAB:F1,6Pi± FBAB:DHAP:G3P 4± G3P + FBAB:DHAP
FBAB:DHAP:± DHAP + FBAB
PYR + PDH --± PDH:PYR_1
NAD + PDH:PYR_14± PDH:PYR 1:NAD-+ accoa + PDH:NADH
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PDH:NADH ± PDH + NADH
PYR + PDH:PYR_14± PDH:PYR_2
NAD + PDH:PYR_2W± PDH:PYR_2:NAD- accoa + PDH:NADH:PYR_1
PDH:NADH:PYR1lg NADH + PDH:PYR_1
PYR + PDH:PYR_2W± PDH:PYR_3
NAD + PDH:PYR_3w± PDH:PYR_3:NAD-* accoa + PDH:NADH:PYR_2
PDH:NADH:PYR_2:± NADH + PDH:PYR_2
PYR + PDH:PYR_3* PDH:PYR_4
NAD + PDH:PYR_42W± PDH:PYR_4:NAD-* accoa + PDH:NADH:PYR_3
PDH:NADH:PYR_3W± PDH:PYR_3 + NADH
E4P + DHAPSOO ± DHAPS10
PEP + DHAPSOO ± DHAPSO1
E4P + DHAPSO1± DHAPS1 1
PEP + DHAPSO12:± DHAPSO2
E4P + DHAPSO2-± DHAPS12
E4P + DHAPS1I DHAPS20
PEP + DHAPS 1 0:± DHAPS 11
E4P + DHAPSI I W DHAPS21
PEP + DHAPSI 11± DHAPS12
PEP + DHAPS20W± DHAPS21
E4P + DHAPS12:± DHAPS22
PEP + DHAPS21 ± DHAPS22
DHAPS22-* S3P + DHAPS I
NAD + TCA14- TCA1:NAD
OXA + TCAI:NAD7± TCA1:NAD:OXA
Accoa + TCAI:NAD:OXAW± TCAI:NAD:OXA:accoa-- NADH + TCA1:KG
TCA1:KG W TCA1 + KG
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NAD + TCA2*± TCA2:NAD
KG + TCA2:NAD ± TCA2:NAD:KG-* TCA2:SCOA + NADH
TCA2:SCOAW± TCA2 + SCOA
NAD + TCA3*± TCA3:NAD
SCOA + TCA3:NAD: TCA3:NAD:SCOA4 TCA3:OXA + NADH
TCA3:OXA-± TCA3 + OXA
NADH + OPEOO- OPE10
NADH + OPEIO4 OPE20
OPE20 + 02 -- OPE21-* NAD + OPE11
OPE1 1 -* NAD + OPE00
PYR + accoa-* accoa
F1,6P + GPATO.± GIPATI
F1,6P + G1PAT1g± G1PAT2
GIP + G1PATO.± G IPATOA -+ PolySac + GIPATO
GIP + G1PATl W± G1PATA-* PolySac + GIPATI
GIP + GlPAT2W± G1PAT2A-* PolySac + G1PAT2
G6P + PGI ;4±PGI:G6P:± F6P + PGIj± PGI:F6P
6PG + PGIi PGI:6PG
6PG + PGI:6PGi± PGI:6PG:6PG
F6P + PGI:6PGW± PGI:6PG:F6PW± G6P + PGI:6PGi± PGI:6PG:G6P
F6P + PFKA_0_0i± PFKA_1_0-* F1,6P + PFKA_0_0
F6P + PFKA_1_0± PFKA_2_0-+ F1,6P + PFKA_1_0
F6P + PFKA_2_0--± PFKA_3_0-* F1,6P + PFKA_2_0
F6P + PFKA_3_0± PFKA_4_0-+ F1,6P + PFKA_3_0
F6P + PFKA_4_0:i± PFKA_5_0-* F1,6P + PFKA_4_0
F6P + PFKA_5_0± PFKA_6_0-* F1,6P + PFKA_5_0
F6P + PFKA_6_0± PFKA_7_0-- F1,6P + PFKA_6_0
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F6P + PFKA_7_0± PFKA_8_0-* F1,6P + PFKA_7_0
F6P + PFKA_8_0± PFKA_9_-0 * FI,6P + PFKA_8_0
F6P + PFKA_9_0#± PFKA_10_0-* F1,6P + PFKA_9_0
F6P + PFKA_10_0 W PFKA_11_0 -* F1,6P + PFKA_10_0
Repeat the above for PFKB
PEP + PFKA_0_0* PFKA_0_1
PEP + PFKA_0_1± PFKA_0_2
PEP + PFKA_0_2i± PFKA_0_3
PEP + PFKA_0_3j± PFKA_0_4
F1,6P + FBP ± FBP:F6Pi± F6P + FBP
PEP + PYKF00 PYKF 10-* PYR + PYKFOO
PEP + PYKF10± PYKF20-* PYR + PYKF10
PEP + PYKF20 # PYKF30-* PYR + PYKF20
PEP + PYKF304± PYKF40-* PYR + PYKF30
PEP + PYKF0GIW± PYKF1 1-* PYR + PYKFOI
PEP + PYKFI IW± PYKF21-+ PYR + PYKFI 1
PEP + PYKF21 ± PYKF31-I PYR + PYKF21
PEP + PYKF31 W± PYKF41 PYR + PYKF31
F1,6P + PYKF00 PYKFO1
Repeat above for PYKA
PYR + PPSA t PPSA:PYR i PPSA:PEP W PEP + PPSA
S3P + E1± EI:S3P
PEP + E1:S3Pi E1:S3P:PEP-+ PYR + EI:13G
E1:13G-+ 13G + El
13G + E2 ;i± E2:13G -- G3P + E2
NADPH -* NADP
GicEx + GT*± GT:GlcEx-* GT + GlcIn
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GlcIn + HXK:± HXK:GlcIn-* G6P + HXK
PYR + EOLE4± EOLE:PYR
NADH + EOLE:PYRW± EOLE:PYR:NADH-* NAD + EOLE:EOL
EOLE:EOL-* EOLE + EOL
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